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De	même,	 l'homme	absurde,	quand	il	contemple	son	tourment,	fait	taire	toutes	 les	 idoles.	
Dans	 l'univers	 soudain	 rendu	 à	 son	 silence,	 les	mille	 petites	 voix	 émerveillées	 de	 la	 terre	







sa	mort.	Ainsi,	persuadé	de	 l'origine	 tout	humaine	de	 tout	 ce	qui	est	humain,	aveugle	qui	
désire	voir	et	qui	sait	que	 la	nuit	n'a	pas	de	 fin,	 il	est	 toujours	en	marche.	Le	rocher	roule	
encore.	











All	 Sisyphus’	 silent	 joy	 is	 contained	 therein.	 His	 fate	 belongs	 to	 him.	His	 rock	 is	 his	 thing.	







































































A	 3D	 visualisation	 method,	 allowing	 the	 study	 of	 the	 binding	 topography	 of	 the	 spatial	
distribution	of	pDNA	and	BSA	adhered	to	Q	ligands	within	particles	was	developed.	This	CLSM	
method	 revealed	 imperfections	on	 the	 surface	of	 adsorbents,	providing	additional	binding	
sites	for	pDNA	due	to	micro	crevices.	
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directly	 interconnected	 with	 subsequent	 parts	 of	 this	 thesis,	 focussing	 on	 the	 practical	
implementation	of	a	DSP	unit	operation	for	nanoplex	purification.	However,	as	nanoplex	of	
choice	throughout	the	study	pDNA	was	chosen.	
It	 is	 hence	 desired	 to	 give	 the	 reader	 an	 introductory	 overview	 over	 a	 promising	 field	 of	
application.	
1.1.1.	Overview	







first	 approved	 successful	 gene	 therapy	 in	 human	 was	 conducted	 in	 1990,	 when	 Ashanti	




This	 and	 other	 early	 breakthroughs	 sparked	 scientific	 enthusiasm	 for	 gene	 therapy	 and	
conceptually	similar	pDNA	vaccination	using	viral	vectors	as	delivery	vehicles.	In	1999,	Jesse	






Despite	 the	 sorrowful	 1999	 setback,	 from	 1989	 to	 2018,	 more	 than	 2800	 clinical	 trials	
associated	with	gene	 therapy	were	conducted	 (Edelstein,	2018)	and	 in	2003	 the	 first	gene	
therapy	 product	 “Gendicine“	was	 approved	 for	 clinical	 use	 in	 humans.	 It	 is	 a	 cancer	 gene	
therapy	delivering	 the	 tumor	 suppressor	 gene	p53	 via	 a	 recombinant	 adenovirus	 and	was	
approved	by	the	Chinese	Food	and	Drug	Administration	for	the	treatment	of	squamous	cell	
carcinoma	(Pearson	et	al.,	2004;	Wilson,	2005).	The	first	gene	therapy	treatment	receiving	
approval	 in	 the	 Western	 World	 by	 the	 European	 Medicines	 Agency	 (EMA)	 was	 Glybera,	
designed	for	reversion	of	 lipoprotein	 lipase	deficiency	(uniQure,	2012).	Recently,	 in	August	




Generally,	 gene	 therapy	 aims	 to	 cure	 genetic	 disorders,	 caused	 by	mutations	 in	 the	 gene	


















with	 the	 therapeutic	 genetic	 material,	 optionally	 multiplied	 in	 a	 laboratory	 and	 (re-)	
administered	to	the	patient.	Modifying	cells	outside	the	human	body	is	generally	preferred	as	
it	 allows	 for	harsh	 transfection	 conditions	 (e.g.	 electroporation	etc.)	 to	be	used	and	 limits	
genetic	alteration	to	the	target	cell	population.	However,	these	techniques	are	limited	to	cells	
amenable	to	surgical	removal	and	re-administration	(i.e.	blood	cells,	skin	cells)	and	often	fail	
for	 cell	 types	 requiring	 embedding	 in	 intricate	 functional	 networks	 for	 their	 function	 (i.e.	









gene	 therapy	 as	 a	 therapeutic	 treatment	of	 diseases	 remains	 a	 delivery	 challenge	 to	date	
(Gonçalves	et	al.,	2017).	Ideally,	delivery	of	exogenous	DNA	is	cell	type	specific	and	provides	
a	precise	amount	of	genetic	material	being	delivered	to	each	cell,	allowing	for	gene	expression	





vector	 based	 strategies	 (i.e.	 gene	 transfer	 via	 viral	 vectors	 is	 called	 transduction	 cf.	
transfection	for	non-viral	vectors	(Biceroglu	et	al.,	2005;	Ramamoorth	et	al.,	2015).	
1.1.3.	Non-viral	delivery	strategies	


































Delivery	 via	 the	use	of	 photoporation	 is	 in	 concept	 similar	 to	 electroporation.	 Single	 laser	
pulses	 shoot	 holes	 into	 cell	 membranes	 leading	 to	 uptake	 of	 genetic	 material	 through	
transient	 pores.	 The	 technique	 is	 still	 in	 an	 early	 experimental	 stage,	 lacking	 documented	
clinical	application	(Li	et	al.,	2007;	Ramamoorth	et	al.,	2015).	
Magnetofection	couples	therapeutic	genes	to	magnetic	nanoparticles	which	can	be	kept	at	
the	 target	 site	 via	 strong	 external	 magnets.	 Following	 enzymatic	 cleavage	 of	 crosslinking	
molecules	in	the	complex,	DNA	molecules	are	released.	The	technique	mostly	finds	application	
‘in	 vitro’	 (Dobson,	 2006).	 Other	 physical	 methods	 include	 hydroporation	 and	 mechanical	
massage	(Herweijer	et	al.,	2007;	Su	et	al.,	2012)	




















in	 gene	 expression	 (Parker	 et	 al.,	 2003).	 Linking	 neutral	 colipids	 such	 as	











polymerosomes	 protect	 the	 enclosed	 NA	 against	 degradation	 until	 its	 release	 into	 the	
cytoplasm.	However,	delivery	via	synthetic	polymers	offers	several	advantages	over	liposome	




















such	 as	 high	 transduction	 efficiency	 and	 targeting	 precision	 in	 vivo	 (Selvam	 et	 al.,	 2006).	
Furthermore,	physical	and	chemical	methods	demand	repeated	dosage	applications,	whereas	
fewer	(single)	administrations	may	be	sufficient	for	viral	delivery	methods	(Xi	et	al.,	2003).		
The	 main	 disadvantages	 for	 the	 application	 of	 viral	 vectors	 as	 gene	 delivery	 vehicles	 are	
associated	 with	 safety	 concerns	 (immunogenicity	 and	 insertional	 mutagenesis),	 size	










In	 order	 to	 replicate,	 viruses	 introduce	 their	 genetic	 material	 into	 (human)	 host	 cells	 by	
tricking	its	cellular	machinery	to	use	the	viral	genome	as	a	blueprint	for	replication.	Integrating	
viruses	hereby	insert	their	genome	at	a	specific	spot	in	the	genome.	Scientists	have	utilised	
this	 property	 by	 altering	 viruses	 to	 transduce	 therapeutic	 genes	 instead	 of	 their	 own.	
Elimination	of	 obligate	 viral	 genes	 has	 led	 to	 replication	deficient	 viruses	 causing	 reduced	
biosafety	concerns	as	they	require	complementation	of	helper	genes	for	successful	replication	
only	possible	in	laboratory	environment.	(Mali,	2013).	Among	other	integrating	viral	vectors,	
retroviruses	 (such	 as	 lentiviruses),	 and	 adeno-associated-virus	 have	 shown	 the	 most	
promising	transduction	results	in	clinical	trials	(Verma,	2013;	Yin	et	al.,	2017).	
Retroviruses	 can	 either	 be	 replication-competent	 or	 replication-defective.	 The	 biggest	
limitations	for	the	use	of	retroviruses	as	gene	delivery	vehicles	are	the	limited	size	of	the	gene	
insert	they	can	accommodate	(between	8-10	kbp	for	replication	defective	retroviruses),	and	
the	 requirement	 for	 cells	 to	be	 actively	 dividing	 for	 transduction	 (Coffin	 et	 al.,	 1997).	 The	
theoretical	fear	of	insertional	mutagenesis	causing	leukaemia	or	cancer	became	reality	when	
20%	 of	 patients	 involved	 in	 a	 gene	 therapy	 clinical	 trial	 aiming	 to	 treat	 X-linked	 severe	
combined	 immunodeficiency,	 using	 a	 retroviral	 formulation	 in	 2002,	 developed	 leukaemia	
(Hacein-Bey-Abina	et	al.,	2002).	




























































































In	 addition	 to	 treating	 diseases,	 plasmids	 can	 be	 used	 as	 DNA	 vaccines	 for	 genetic	
immunization	against	several	ailments.	Vaccines	have	changed	the	quality	and	span	of	human	
life	 since	 their	 discovery	 and	 many	 diseases	 such	 as	 polio	 and	 tuberculosis	 have	 been	
eradicated	 in	the	western	world,	due	to	the	availability	of	respective	vaccines.	Many	more	
previously	 epidemic	 maladies	 can	 nowadays	 be	 contained	 and	 controlled	 due	 to	 the	
introduction	of	their	vaccine.		
These	 traditional	 vaccines	 work	 by	 presenting	 the	 patient’s	 immune	 system	 with	 an	
immunogenic	 antigen	 via	 oral	 gavage	 or	 direct	 injection	 and	 causing	 an	 immune	 reaction	




techniques,	 patient	 immunity	 does	 not	 require	 long-term,	 sustained	 expression	 of	 the	
transduced	antigen	and	instead	can	be	accomplished	in	short-term	gene	expression.	To	invoke	
an	 immune	 response,	 pDNA	 is	 injected	 into	 (predominantly)	 muscle	 tissue,	 where	 it	 is	
translated	 into	 an	 antigen	 protein.	 Plasmids	 as	 therapeutic	 agents	 in	 vaccination	 work	
differently	 than	 traditional	 vaccines,	 as	 they	 can	 stimulate	 the	 human	 immune	 system	 to	
produce	 both	 humoral	 and	 cellular	 responses,	 including	 the	 production	 of	 cytotoxic	 T	
lymphocytes	(Phillips,	2001).		
In	comparison	to	traditional	types	of	vaccination	such	as	live	attenuated	viruses,	weakened	
bacterial	 strains,	modified	endotoxins,	 viruses	etc.,	 pDNA	vaccines	 are	 considered	 safe	 for	
administration	and	tolerated	by	human	hosts.	Further	advantages	over	conventional	vaccines	











tuberculosis	 (Bruffaerts	 et	 al.,	 2014)	 as	 well	 as	 many	 other	 diseases	 are	 currently	 being	
developed.	Furthermore,	DNA	vaccines	have	also	been	 investigated	as	a	means	to	prevent	




pDNA	 could	 become	 a	 necessity	 to	 satisfy	 future	 needs	 for	 large	 scale	 pDNA	 vaccination	
applications	(Aldridge,	2006).	
	
This	 demand	 puts	 the	 pressure	 on	 engineers	 to	 develop	 scalable,	 cost-effective	methods	








of	pDNA	 to	 target	 cells.	However,	 all	of	 those	processes	 require	highly	purified	pDNA	and	
plasmids	have	become	an	indispensable	tool	for	the	biotechnological	industry,	crucial	for	the	
production	 of	 pharmaceutical	 proteins,	 antibodies,	 vaccines,	 enzymes	 and	 molecular	





For	 the	 development	 of	 a	 successful	 production	 and	 purification	 method	 of	 pDNA,	 an	





Most	 commonly,	 plasmids	 can	 be	 found	 as	 double	 stranded	 (ds)	 DNA	 ring	 structures	 in	
bacteria,	 where	 they	 carry	 at	 least	 one	 specialised	 gene	 responsible	 for	 conditional	
characteristics	 in	 the	cell	 (e.g.	antibody	resistances;	adaptive	metabolic	 functions,	allowing	
the	 host	 to	 survive	 on	 different	 nutrient	 sources;	 ability	 to	 metabolise	 otherwise	 toxic	







by	 phosphodiester	 bonds	 (Figure	 1-6).	 Each	 nucleotide	 comprises	 of	 three	 components;	 a	
nitrogenous	base	(either	adenine,	guanine,	cytosine	or	thymine),	a	2-desoxyribose	and	at	least	
one	phosphate	group	(Lodish,	2000).	DNA	is	a	polymer	comprising	of	repeating	nucleotides,	
forming	 two	 helical	 chains,	 linked	 together	 via	 hydrogen	 bonding	 (secondary	 structure)	
(Watson	et	al.,	1953).	These	chains	are	coiled	around	the	same	axis	with	a	diameter	of	~2	nm	



































concatamers)	can	occur	 (Summers,	2009;	Higgins	et	al.,	2015).	Sizes	of	pDNA	 intended	 for	
vaccination	 range	 typically	 from	3-15	kilo	base	pairs	 (kbp),	with	estimations	 that	 sizes	will	
increase	in	the	future	(Levy	et	al.,	2000).	Although	stable	in	solution,	pDNA	is	shear	sensitive	

















Medicines	 Evaluation	 Agency	 (EMEA),	 World	 Health	 Organization	 (WHO),	 Food	 and	 Drug	
Administration	(FDA)	and	others,	depending	on	the	targeted	market	(Epstein,	1996).	Beside	







Endotoxin	 level	 (assessed	 by	 Limulus	 amebocyte	
lysate	(LAL)	test)	
<0.5	endotoxin	units	(EU)/mg	pDNA	












maximizing	 plasmid	 yield	 in	 each	 (Figure	 1-8).	 In	 a	 very	 broad	 sense,	 the	 production	 of	








Historically	 yields	have	been	very	 low	 (<200	mg/L)	however,	 recent	 advances	 in	upstream	

























































Among	 other	 DSP	 operations,	 chromatography	 in	 its	many	 forms	 is	 still	 the	most	 applied	
method	 throughout	 the	 industry	 (Xenopoulos	 et	 al.,	 2014).	 Its	 importance	 throughout	











Parameter	 oc	pDNA	 sc	pDNA		 gDNA	 RNA	 Endotoxins	
Size	 X	 X	 X	 	 X	
Negative	charge	 X	 X	 x	 X	 X	
Hydrophobicity	 X	 X	 	 	 	














topological	 constraints	 based	 on	 the	 molecules	 conformation	 can	 all	 be	 exploited	 to	
selectively	separate	sc	pDNA	from	contaminating	impurities	and	other	pDNA	conformations	
(Ferreira	et	al.,	2000b).	
One	 way	 to	 categorise	 chromatographic	 purification	 strategies	 is,	 (i)	 by	 the	 mode	 of	




chromatography	 (HIC),	 affinity,	 etc.)	 the	 target	 product	 binds	 to	 ligands	 provided	 on	 the	
surface	of	a	stationary	phase.	A	reversion	of	attractive	forces,	by	changing	the	environmental	
conditions,	subsequently	elutes	bound	moieties	from	the	ligands	on	the	basis	of	their	strength	




hydroxyapatite	 or	 sintered	 glass),	 synthetic	 organic	 polymers	 (polystyrene,	 methacrylate,	
polyacrylamide)	or	natural	organic	polymers	(cellulose,	dextran,	amylose,	agarose)	(Leonard,	
1997).	Due	to	 its	mechanical	and	chemical	stability,	neutral	charge,	hydrophilic	nature	and	












formation	 of	 agarose	 based	 adsorbents	 a	 challenging	 process,	 with	 a	 high	 propensity	 for	
batch-to-batch	 variations	 (Gilbert,	 2018).	 Advantages	 of	 agarose	 based	 beaded	
chromatography	 media	 as	 well	 as	 other	 natural	 occurring	 polymers	 are	 their	 very	 low	
unspecific	 adsorptivity	 as	well	 as	 excellent	 flow	properties	 due	 to	 the	 use	 of	 cross-linking	
chemistry	enhancing	their	rigidity	(Jungbauer,	2005).		
	 -	23	-	











Together	 with	 size	 exclusion	 chromatography	 (SEC),	 AEC	 is	 the	 most	 widely	 applied	



















results	 in	 very	 poor	 binding	 capacities	 of	 pDNA	 to	 AEC	 resins	 (0.2-2	 g/LSBV	 vs		
10-100	g/LSBV	 in	protein	purification)	 (Prather	 et	al.,	 2003).	With	 typical	pore	diameters	of	
around	25	nm	(for	beaded	resins	of	6%	agarose	content	(Hagel	et	al.,	1996b))	pDNA	molecules	




40%	 still	 barely	 utilises	 a	 fraction	 of	 binding	 area	 in	 comparison	 to	 a	 protein	 purification	
column	(Colpan	et	al.,	1984;	Murphy	et	al.,	1999;	Murphy,	2003;	Sagar,	2003).	
The	 introduction	 of	 superporous/	 perfusion	 beads	 increases	 the	 available	 binding	 area	 of	












charged	 contaminants	 such	 as	 high	 molecular	 weight	 RNA	 and	 endotoxins	 hard	 to	 avoid	
(Ferreira	et	al.,	2000b).	Superior	elution	can	be	achieved	using	shallow	salt	gradients	during	
	 -	25	-	










elute	 first,	 while	 smaller	molecules	 have	 a	 longer	 diffusional	 pathway,	 resulting	 in	 longer	
retention	times	(Ferreira	et	al.,	1997).	Different	pDNA	isoforms	are	eluted	as	a	 function	of	
their	 effective	 size	 (Potschka,	 1991),	 with	 gDNA	 eluting	 first	 followed	 by	 linear	 and	 open	
circular	(oc)	pDNA	(Moreau	et	al.,	1987).	The	compact	structure	of	sc	pDNA	leads	to	a	reduced	
size	in	comparison	to	other	conformations	and	causes	the	molecule	to	elute	last	(Urthaler	et	




combining	 a	 rigorous	 removal	 of	 residual	 impurities	 with	 a	 buffer	 exchange	 step	 in	






















the	 feed	 (Leonard,	1997),	 that	has	been	applied	 for	pDNA	purification	 (Diogo	 et	al.,	 2000;	
Freitas	et	al.,	2009b;	Pereira	et	al.,	2010).	
The	retention	time	of	NA	molecules	in	HIC	columns	is	predominantly	determined	by	their	size,	
base	composition	and	secondary	 structures	 (Colote	 et	al.,	1986)	 In	aqueous	 solution,	DNA	
forms	 a	 double	 helix	 structure,	 exposing	 its	 hydrophilic	 phosphate	 backbone	 to	 the	
surrounding	buffer,	while	keeping	its	aromatic	bases	tucked	away	inside	the	tertiary	structure	
(Li	 et	al.,	 2005).	While	 the	double-stranded	nature	of	NA	 is	 intact,	 its	 interaction	with	HIC	




concentration.	 In	 a	 final	 step,	 strongly	 bound	 molecules	 (linear	 pDNA,	 denatured	 gDNA	
fragments,	 RNA)	 are	 stripped	 from	 the	 column	 and	 the	 column	 regenerated	 for	 future	
applications	(McCue,	2014).		
In	 an	attempt	 to	minimise	 the	 reliance	on	 the	hazardous	 ammonium	sulphate,	 the	use	of	
potassium	phosphate	has	been	investigated,	yielding	99%	pDNA	purity	(Bonturi	et	al.,	2013).	
Despite	a	low	recovery,	the	purity	of	the	formulation	is	enough	to	meet	international	vaccine	
purity	 recommendations	 and	 the	 cleanliness,	 cost	 effectiveness	 and	 speed	 of	 the	method	










reversibly	with	 immobilised	 ligands	with	high	 specificity	 through	 several	different	 types	of	
bonds	and	interactions	(Ninfa	et	al.,	2010).	It	has	the	unique	ability	to	purify	biomolecules	via	

















not	have	any	exposed	purine	bases	 in	 the	sc	 isoform,	 the	 technique	has	been	successfully	




of	 different	 proteins	 and	 amino	 acids	 in	 biological	 organisms.	 These	 interactions	 mainly	
involve	 basic	 amino	 acids	 such	 as	 histidine	 or	 arginine	 (Sousa	 et	 al.,	 2010a)	 and	 involves	





















electrostatic	 forces.	 Purification	of	 a	 5.17	 kbp	plasmid	 from	other	 lysate	 components	 in	 a	
















The	 use	 of	 conventional	 chromatography	 for	 the	 purification	 of	 pDNA	 formulations	 is	
attributed	to	several	challenges,	 inherent	to	the	structural	nature	of	beaded	supports.	The	
availability	of	binding	sites	 for	pDNA	being	 limited	to	particle	surfaces	and,	as	a	result	 low	
binding	 capacities	 of	 beaded	 supports	 have	 inspired	 researchers	 to	 find	ways	 to	 improve	




























improved	 by	 enhancing	 charge	 density	 on	 small	 beads	 in	 conjuncture	 with	 grafting	













as	 slightly	 enhanced	pDNA	 capacity	 (Meyer,	 2013).	 The	 internal	 structure	of	macroporous	
beads	comprises	of	two	differently	sized	pore	types,	namely	flow	through	pores	(6000-8000	Å)	
and	diffusive	pores	(800-1500	Å),	allowing	for	deeper	penetration	and	binding	of	pDNA	to	the	
particles	 as	 well	 as	 quicker	 elution	 times	 (Deshmukh	 et	 al.,	 2005;	 Tiainen	 et	 al.,	 2007a;	
Arpanaei,	2008).	













The	 fragile	 nature	 of	 nanoplex	 bioproducts	 and	 the	 avoidance	 of	 binding	 in	 negative	
chromatography,	 have	 made	 this	 technique	 appealing	 to	 researchers,	 however	 the	
electrostatic	similarities	between	pDNA	and	its	contaminates	in	the	feed	make	adaptation	of	
the	 technique	 for	 pDNA	 purification	 challenging	 outside	 of	 affinity	 based	 purification	
strategies	(Caramelo-Nunes	et	al.,	2014).	
	








In	 order	 to	 be	 able	 to	 capture	 nanoplex	 molecules	 in	 the	 flow	 through	 while	 retaining	






molecules,	 while	 the	 inert	 outer	 shell	 layer	 prevents	 adsorption	 of	 pDNA.	 This	 type	 of	




Although	 separation	media	based	on	multilayer	 structures	have	 found	wide	 application	 in	
analytical	 techniques	 (high	 performance	 liquid	 chromatography	 (HPLC)),	 the	 use	 and	
development	 for	media	 targeted	 for	 large	 scale	 production	 of	 nanoplex	 biomolecules	 is	 a	
comparatively	new	approach	(Haginaka,	1991;	Pinkerton,	1991;	Hayes	et	al.,	2014;	de	Faria	et	
al.,	2017).	Several	different	manufacturing	approaches	have	been	explored	to	provide	XEC/	
SEC	bilayered	media	(X-	several	modes	of	 ligand	 interaction	are	conceivable,	such	as	 ionic,	
hydrophobic,	 multimodal,	 etc.)	 for	 the	 purification	 of	 large	 target	 products	 from	 smaller,	
chemically	similar	contaminants.	
Coating	an	AEC	Amberlite	matrix	by	adsorbing	negatively-charged,	hydrophilic	polyacrylic	acid	














coated	 by	 an	 agarose	 gel,	 reducing	 non-specific	 binding	 of	 cells	 and	 cell	 debris,	 while	
maintaining	the	core’s	ability	for	selective	capturing	of	target	proteins.	The	non-stick	exterior	
was	reported	to	reduce	bead	fouling	and	inter-particle	cross-linking,	leading	to	improved	bed	





The	 first	 SEC-AEC	 bilayered	 media	 for	 pDNA	 purification	 in	 a	 packed	 column	 was	 first	
introduced	by	Gustavsson	 in	2004	(Gustavsson	et	al.,	2004).	 Instead	of	 laminating/	coating	
pre-functionalised	 AEC	 supports,	 the	 researchers	 applied	 an	 allyl	 glycidyl	 ether	 (AGE)	











of	an	outer	 layer,	 followed	by	hydrolysis	of	allylated	beads,	 (iii)	coupling	of	the	strong	AEC	
ligand	Q	(quaternary	amine)	throughout	the	core	of	the	supports.	
Light	micrographs	of	Congo	red	(CR)	stained	beads	showcase	a	distinct	separation	of	a	charged	
core	 surrounded	by	a	 thin	 inert	outer	 layer.	The	 ‘lid	beads’	were	applied	 in	a	 two-column	
strategy	for	pDNA	purification	of	a	5.9	kbp	plasmid	from	crude	E.	coli	lysate	with	89%	yield,	
removing	99.5%	of	endotoxins	and	96%	HCP	(Gustavsson	et	al.,	2004).	The	media	was	further	























of	 bilayered	 supports	 via	 the	 AGE	 activation-	 partial	 bromination	 route,	 to	 keep	 the	 shell	
thickness	as	thin	as	possible.	To	achieve	such	thin	non-adhesive	layers,	the	diffusion	pathway	
of	bromine	into	the	bead	has	to	be	as	short	as	possible	while	maintaining	a	homogenous	layer	
shape.	 The	 very	 fast	 convective	 transport	 of	 bromine	 in	 aqueous	 solution	 to	 the	 particles	
	 -	36	-	






pores	 of	 AGE	 activated	 supports.	 By	 optimizing	 the	 reaction	 temperature,	 viscosity	 and	
addition	of	additives,	SEC-AEC	media	on	the	basis	of	Sepharose	CL-6B	were	produced.	These	
supports	yielded	selectivity	indices	of	up	to	3.52	in	static	pDNA/	bovine	serum	albumin	(BSA)	





complete	 elimination	 of	 surface	 charge	 (SI=	 57.4)	 (Karnchanasri,	 2012).	 Plasma	 irradiation	
treatment	 of	 material	 surfaces	 is	 a	 well-established	 technology	 that	 is	 used	 for	 the	
modification	of	surface	properties	at	the	‘nano-scale’	(Fisher,	2002).	
Plasma	 treatment	 of	 material	 surfaces	 has	 several	 advantages;	 (i)	 low	 operational	
temperatures	 (room	temperature);	 (ii)	 shallow	 ‘nano-scale’	modifications	can	be	achieved,	
without	changing	the	bulk	properties;	(iii)	modification	of	various	types	and	compositions	of	
surfaces;	and	(iv)	no	generation	of	large	amounts	of	toxic	by-products	(Schram	et	al.,	1987).	




The	 application	 of	 low	 temperature	 glow	 discharge	 plasma	 irradiation	 treatments	 for	
modification	 of	 AEC	 media	 surfaces	 has	 been	 demonstrated	 to	 prepare	 bilayered	




oxidizing,	 oxygen	 containing	 groups	 (‘plasma	 etching	 and	 oxidation’);	 (ii)	 coating	 surface	










Many	 common	 chromatography	 adsorbents	 such	 as	 Sepharose	 and	 Sephacryl	 have	 a	 soft	
hydrogel	 structure.	Under	 aqueous	 condition	 at	 atmospheric	 pressure,	water	 accounts	 for	
>90%	of	the	support	volume	and	plays	a	pivotal	structural	role.	Under	low	pressure	conditions,	
water	is	easily	evaporated	from	the	pores	of	these	hydrogels,	resulting	in	a	loss	of	support	




by	Arpanaei.	 The	extension	of	 these	 low	 temperature,	 low	pressure	plasma	 treatments	 to	
beaded	hydrogel	chromatographic	support	materials	is	hence	hindered,	by	the	low	pressure	
(~10	Pa)	at	which	 the	plasma	 treatment	was	carried	out.	 Low	 temperature	plasma	can	be	
















a	 result	 of	 thermal	 damage	 to	 the	media,	 resulting	 from	 contact	 of	 single	 supports	 with	
intensely	hot	plasma	filaments	during	the	treatment.		
However,	 the	 ease	of	 application	 to	modify	 soft	 hydrogel	 support	media	 in	 their	 aqueous	
(native)	 state	 has	 considerable	 application	 potential	 for	 the	 field	 of	 packed	 bed	
chromatography	(Olszewski	et	al.,	2013).	
Although	initial	uptake	of	restricted	access	media	(RAM)	application	for	nanoplex	purification	





with	 the	 MMC	 ligand	 octylamine,	 employing	 hydrophobic	 and	 electrostatic	 modes	 of	
interaction	for	the	selective	and	efficient	capture	of	impurities.	The	core	is	surrounded	by	an	
agarose	 shell	 of	 approximately	 5	 µm	 thickness	 with	 a	 molecular	 size	 cut-off	 of	 700	 kDa,	
preventing	large	biomolecules	from	passing	through	the	shell	and	interacting	with	the	core.	
Further	multifunctional	adsorbents	with	options	 to	modulate	different	properties	and	vary	
multiple	parameters	 in	designing	a	separation	protocol,	 including	porosity,	bead	size,	 layer	
thickness,	pore	size	distribution,	type	of	ligand,	and	ligand	concentration	have	been	heralded	
(Glaser,	2013).	
However,	 to	 date,	 only	 one	 more	 material	 utilizing	 the	 ‘core	 bead	 technology’	 of	 GE	






efficiency	 more	 than	 10-fold,	 recovering	 ~70%	 of	 cells	 after	 global	 processing,	 without	
compromising	characteristics	of	the	target	cells,	with	cell	viability	above	95%	(Cunha	et	al.,	
2016). 
In	 2018,	 BioToolomics	 introduced	 a	 ‘Negative	 chromatography	 Antibody	 Purification’	
technology	based	on	bilayered	adsorbents.	The	company	offers	a	library	of	MMC	ligands	for	








for	 nanoplex	 purification,	 in	 a	 single	 negative	 chromatography	 mode	 purification	 step,	
creating	a	SE	shell	surrounding	a	charged	core.	
Early	successes	applying	plasma	etching	and	oxidation	techniques	to	selectively	modify	the	














confocal	 laser	 scanning	 microscopy	 (CLSM),	 Environmental	 Scanning	 Electron	 Microscope	
(ESEM)	and	light	microscopy	this	study	aims	to	identify	the	origin	of	the	residual	binding	sites	
and	 if	 possible	 adjust	 the	 manufacturing	 protocol	 to	 enhance	 selectivity	 by	 eliminating	
remaining	surface	charges.	
With	 CC700	 being	 the	 first	 marketed	 restricted	 access	 media	 for	 nanoplex	 purification,	
chapter	five	focusses	on	the	characterization	of	the	media.	Furthermore,	the	medias	suitability	



















Sepharose	 Cl-6B	 were	 purchased	 from	 GE	 Healthcare	 Bio-Sciences	 (Uppsala,	 Sweden).	

























For	 the	 Orcinol	 assay,	 Orcinol,	 iron(III)	 chloride,	 hydrochloric	 acid,	 ribonucleic	 acid	 from	
baker’s	 yeast	 (S.	 cerevisiae)	 were	 purchased	 from	 Sigma-Aldrich	 Company	 (St.	 Louis,	MO,	
USA).		
For	 static	 binding	 studies,	 BSA,	 100x	 TE	 (10	mM	Tris-Cl;	 1	mM	EDTA;	 pH	7.5)	 buffer	were	
purchased	 from	Sigma-Aldrich	Company	Ltd.	 (St.	 Louis,	MO,	USA).	Hoechst	dye	33258	was	
purchased	 from	 Molecular	 Probes,	 Invitrogen	 (Eugene,	 Oregon,	 USA).	 Sodium	 azide	 was	
purchased	from	Sigma-Aldrich	Company	Ltd.	(St.	Louis,	MO,	USA).	




Invitrogen	Molecular	 Probes	 Cy5	 dye	was	 purchased	 from	Thermo	 Scientific	 (Rockford,	 IL,	
USA).	 Syto	 9	 green	 fluorescent	 nucleic	 acid	 stain	 was	 purchased	 from	 Lifetechnologies	
(Eugene,	Oregon,	USA).	VWR	VistaVision	Microscope	 Slides	 and	VWR	Micro	Cover	Glasses	
were	purchased	from	VWR	International	Ltd	(Lutterworth,	Leicestershire,	UK).		













































media	 (containing	 100	 µg/mL	 ampicillin)	 and	 incubated	 for	 1	 h	 (37°C)	 to	 assist	 the	
development	of	antibiotic	resistance.		
















batch	 mode,	 using	 the	 following	 (starting)	 conditions;	 4	 L	 of	 LB	 media,	 30	 g/L	 glucose,	

















by	 6	 times	 inversion,	 the	 sample	was	 incubated	 at	 room	 temperature	 (5	min).	 Prechilled	
neutralisation	buffer	P3	was	added	(125	mL),	thoroughly	mixed	and	incubated	on	ice	(30	min).	













For	 the	 production	 of	 cleared	 E.	 coli	 lysate	 for	 frontal	 loading	 column	 chromatography	





36	 mL	 resuspension	 buffer	 (10	 mM	 Tris-HCl;	 61	 mM	 glucose;	 50	 mM	 ETDA;	 pH	 8).	 The	



















200	µL	 of	 sample	 were	 added	 to	 200	µL	 of	 phenol:	 chloroform:	 isoamyl	 alcohol	 solution	













Sequencing	 of	 the	 plasmid	 has	 been	 performed	 via	 Sanger	 capillary	 sequencing	 using	 the	



















































































Current	 and	 voltage	 were	 measured	 with	 a	 Pearson	 Current	 Monitor	 2877	 (Pearson,	





































To	 investigate	 the	 influence	 of	 slurry	 temperature	 during	 plasma	 etching	 treatment,	 the	
reactor	was	modified	by	adding	a	stirred	ice	bath	(Figure	2-6).	The	cooling	tank	was	directly	


























HCl;	 1	mM	disodium	 EDTA;	 pH	 8.0)	 in	 a	 10x	 suspension	 for	 ease	 and	 precision	 of	 sample	
handling.	The	supports	were	aliquoted	into	750	µL	(75	µL	settled	bed	volume	(SBV))	aliquots,	
allowed	to	settle	and	the	supernatant	was	carefully	pipetted	out.	The	beads	were	incubated	






HCl;	 1	mM	disodium	 EDTA;	 pH	 8.0)	 in	 a	 10x	 suspension	 for	 ease	 and	 precision	 of	 sample	
handling.		
The	 supports	 were	 aliquoted	 into	 750	µL	 (75	µL	 SBV)	 aliquots,	 allowed	 to	 settle	 and	 the	
supernatant	was	carefully	pipetted	out.	The	beads	were	incubated	with	1.5	mL	BSA	solution	
(concentration	 dependent	 on	maximum	binding	 capacity	 of	 respective	media)	 on	 a	 blood	
rotor	 shaker	 SB1	 (Stuart	 Scientific;	 Staffordshire;	 UK)	 for	 1	 h.	 Then	 the	 samples	 were	















For	 small	 numbers	 of	 samples	 (highly	 pure	 BSA	 samples	 in	 TE	 buffer),	 a	 simple	
spectrophotometric	 assay	was	 used.	 Protein	 solution	 (900	µL)	was	 pipetted	 into	 a	 quartz	
cuvette	 (path	 length	 10	mm;	 Suprasil,	 Hellma	Analytics,	UK)	 and	 the	OD280	was	measured	
(Evolution	 300,	 Thermo	 Fisher,	Madison,	 USA).	 The	 protein	 concentration	 in	 solution	was	













described	 in	 2.3.3.	 ),	 a	 simple	 spectrophotometric	 assay	 was	 used.	 Plasmid	 DNA	 solution	
(800	µL)	was	pipetted	into	a	quartz	cuvette	and	absorbance	was	measured	at	OD260.	TE	buffer	
(10	mM	Tris-HCl;	1	mM	EDTA;	pH	8.0)	was	used	as	a	blank,	using	a	10	mm	path	length	quartz	
cuvette,	 the	 concentration	 of	 ds	 pDNA	 in	 solution	 and	 the	 optical	 density	 are	 linearly	
correlated	for	OD260	=	0.1	-	1	and	were	calculated	using	the	following	equation	(Barbas	et	al.,	










Hoechst	 dye	 33258	was	 dissolved	 till	 oversaturation	 in	 a	DMSO/MQW	 (1/4-	 v/v)	 solution,	























then	 centrifuged	 (10,000	 g;	 20	 min).	 The	 supernatant	 was	 carefully	 pipetted	 out	 and	
discarded.	The	pellet	was	resuspended	in	250	µL	of	1	M	perchloric	acid	by	vortex	mixing	and	
incubated	on	a	spinning	heating	block	(70°C;	200	rpm;	30	min).	Samples	were	allowed	to	cool	
to	 room	temperature	and	mixed	 thoroughly	with	500	µL	of	 freshly	prepared	chromogenic	


























1.5	 h.	 To	 remove	 excess	 Cl-	 ions	 (from	 both	 the	 supernatant	 and	 unspecifically	 bound	 to	
supports),	the	supports	were	washed	and	drained	five	times	with	50	mL	MQW	on	a	vacuum	
filter.	 The	 drained	 supports	 were	 subsequently	 transferred	 to	 50	 mL	 centrifuge	 tubes	
containing	25	mL	of	0.1	M	NaOH	and	incubated	overnight	on	a	blood	tube	rotator	SB1.	During	
the	incubation	with	NaOH,	excess	OH-	ions	displace	the	Cl-	ions	on	the	beads,	releasing	them	
into	 the	 surrounding	 buffer.	 Supports	 were	 left	 to	 settle	 and	 1	mL	 was	 taken	 for	 Cl-	 ion	
determination.	 
Cl-	 ion	 quantification	 was	 performed	 by	 either	 mixing	 1	 mL	 sample	 or	 calibration	 ladder	
solution	with	both	100	μL	of	0.25	M	ammonium	iron	(III)	sulphate	in	9	M	HNO3	and	100	μL	of	
mercury	(II)	thiocyanate	saturated	in	96%	ethanol.	The	sample	was	then	mixed	vigorously	on	





























chemical	 composition	 of	 the	 surface	 of	 hydrogel	 chromatography	 particles	 lead	 to	 severe	
visual	alteration	(Olszewski	et	al.,	2014).	Several	techniques,	used	in	this	study	to	monitor	the	
visual	 integrity	 post	 plasma	 treatment	 (ESEM,	 light	 microscopy),	 to	 assess	 the	 spatial	
	 -	59	-	
distribution	 of	 protein	 and	 pDNA	 binding	 (CLSM)	 of	 the	 particles	 as	 well	 as	 their	 size	
distributions,	were	therefore	employed.		
2.3.11.1.	Environmental	Scanning	Electron	Microscopy	






80	µL	 of	 chromatography	 supports	 slurry	 in	MQW	were	pipetted	onto	 a	microscope	 slide	
(VWR	VistaVision	Microscope	Slides,	VWR	International,	UK)	and	covered	with	a	cover	glass	
(VWR	Micro	 Cover	Glasses),	 carefully	 avoiding	 the	 formation	 of	 air	 bubble	 inclusions.	 The	
sample	was	 then	analysed	 in	an	Olympus	BX50	 light	microscope	using	4x,	10x,	20x	or	40x	
magnification	 respectively.	 For	 images	 taken	 with	 a	 100x	 magnification,	 a	 droplet	 of	
immersion	oil	(Sigma	Aldrich)	was	used	to	bridge	the	gap	between	the	lens	and	the	cover	slide.	






To	 get	 an	 insight	 into	 the	 spatial	 distribution	 of	 bound	 probes	 (BSA	 and	 pDNA)	 to	
chromatography	media,	CLSM	was	employed.	The	fluorescent	probe	Cy5	was	attached	to	BSA	
according	 to	 the	 following	 protocol	 (due	 to	 light	 sensitivity	 of	 Cy5,	 all	 sample	 tubes	were	
wrapped	in	aluminium	foil	and	kept	away	from	light):	
5	mL	of	BSA	solution	(70	mg/mL)	was	prepared	in	TE	buffer	(10	mM	Tris-HCl,	1	mM	disodium	




calculated	using	the	following	equations:	𝑛 𝐵𝑆𝐴 = A BCD	EFGHIJFK 	∗	L BCD	EFGHIJFKM BCD 		




G-25	media.	 The	 column	was	 equilibrated	 in	 25	mL	 of	 TE	 buffer	 (10	mM	 Tris-HCl,	 1	mM	






pDNA	 solution	 was	 pre-	 stained	 using	 the	 minor	 grove	 binding	 fluorescent	 dye	 Syto	 9	










to	1	dye molecule)	on	a	Stuart	Scientific	SB1	rotor	mixer	for	1	h:	Vsyto	9	working	solution1	mL	pDNA	solution = 1.215	µL		
During	the	assay	development,	 it	was	found	that	a	separation	step,	ridding	the	solution	of	
unconjugated	dye	was	unnecessary	for	subsequent	use	in	the	CLSM	analysis.	This	is	the	result	
























































pressure	 plasmas	 was	 investigated.	 Four	 different	 anion	 exchange	 chromatography	
adsorbents	(Q	Sepharose	Fast	Flow,	DEAE	Sepharose	Fast	Flow,	Q	Hyper	Z	and	EMD	Fractogel	
DEAE)	were	treated	using	plasmas	generated	from	He-O2	admixed	gasses	in	a	Dielectric	Barrier	




between	 the	 sample	 and	 upper	 electrode	 plate	 during	 treatment,	 with	 treatments	 at	 a	
distance	of	4.5	mm	producing	SI	values	up	to	~5	(85%	loss	of	pDNA	binding	with	<25%	loss	of	
BSA	binding).	In	the	fluidised	bed	configuration,	treatment	of	supports	with	a	He-O2	plasma	
produced	supports	with	SI	 values	up	 to	~3,	 corresponding	 to	70%	 loss	of	pDNA	binding	 in	
exchange	for	8%	loss	of	BSA	binding.	
A	 CLSM	 method	 was	 developed	 to	 visualise	 the	 binding	 topography	 of	 BSA	 and	 pDNA,	





Preparative	 chromatography	 is	 considered	a	pivotal	 tool	 in	DSP	 for	 the	biopharmaceutical	
industry	(Ghanem	et	al.,	2013;	Abdulrahman	et	al.,	2018).	
However,	 in	 comparison	 to	 advances	made	 in	 upstream	 production	 of	 biopharmaceutical	




the	 production	 of	 biopharmaceuticals	 (Pinto	 et	 al.,	 2015).	 New	 challenges,	 that	 column	
chromatography	 is	 facing	 include	 increased	 size	 and	 complexity	of	 emerging	bio-products,	
rising	product	 titres,	 increasing	costs	of	goods	and	waste	disposal	 requirements	as	well	as	




functionality’	 approach	 that	 has	 dominated	 the	 chromatographic	 research	 for	 decades,	
solutions	 for	 the	 outlined	 challenges	 can	 be	 achieved	 by	 reimagining	 chromatographic	
separation	based	on	multifunctional	adsorbents.		
Among	more	complex	geometries,	the	simplest	multifunctional	support	design	is	a	bilayered	
adsorbent	 featuring	 a	 ligand	 functionalised	 core	 surrounded	 by	 an	 inert,	 outer	 layer	 that	















































at	 the	 ‘nano-scale’.	 Plasma	 hereby	 is	 defined	 as	 a	 wholly	 or	 partially	 ionised	 medium	
comprising	of	ions,	electrons,	as	well	as	neutral	species	and	photons	(Fisher,	2002;	Arpanaei	
et	 al.,	 2010).	 Advantages	 of	 such	 plasma	 treatments	 include:	 (i)	 operation	 at	 low	 (room)	
temperatures;	(ii)	shallow	modifications	can	be	achieved,	without	altering	the	bulk	properties	
of	 underlying	media;	 (iii)	 suitable	 for	modifying	many	different	 types	 and	 compositions	of	
surfaces;	and	(iv)	no	generation	of	large	amounts	of	toxic	by-products	(Schram	et	al.,	1987).	
Surface	modification	by	plasma	 is	performed	 in	a	reactor	supplied	with	a	suitable	gas	(e.g.	
helium	 admixed	 with	 oxygen	 (Knake	 et	 al.,	 2008;	 Park	 et	 al.,	 2010)).	 An	 electrical	 or	
electromagnetic	supply	of	energy	is	provided	to	ignite	a	plasma	within	the	reactor.	Collisions	
between	 the	 energetic	 plasma	 species	 and	 gas	 particles	 lead	 to	 the	 generation	 of	 highly	
reactive	oxygen	species	suitable	for	carrying	out	surface	modifying	reactions,	such	as	etching	
away	 functionalised	 groups	 off	 substrate	 surfaces	 and	 replacing	 them	 with	 polar	 oxygen	











EBA	 studies	 showed	 that	 10%	 breakthrough	 capacities	 of	 the	 beads	with	 respect	 to	 DNA	
binding	 dropped	 significantly	 after	 plasma	 etching,	 while	 retaining	 their	 protein	 binding	
capacity	of	the	untreated	Q	Hyper	Z.		
Given	 the	 rigid	nature	of	 its	base	matrix,	 transferring	 these	 low	temperature	 low	pressure	
plasma	treatments	to	other	beaded	chromatographic	support	media	is,	however,	hindered	by	
the	 low	pressure	 (~10	Pa)	at	which	 the	plasma	treatment	was	carried	out.	Many	common	
chromatography	adsorbents,	based	on	stationary	phases	 such	as	Sepharose	and	Sephacryl	
have	 soft	 hydrogel	 structures.	 Under	 aqueous	 conditions	 at	 atmospheric	 pressure,	 their	
stationary	phases	comprise	of	swollen	agarose	(or	allyl	dextran-N,Nʹ-methylenebisacrylamide	

























vessel,	 providing	 turbulent	 mixing	 of	 the	 suspension	 during	 treatment	 (Figure	 3-2,	 B).	















Some	 of	 the	 conducted	 experiments	 do	 however	 require	 more	 explanation	 in	 regard	 to	
specific	parameters,	complementing	the	content	of	Chapter	2.	When	further	information	is	


















outer	 shell	 binding	 capacity	 as	 much	 as	 possible,	 while	 maintaining	 a	 high	 core	 binding	
capacity.	To	assess	the	selectivity	of	shell	vs	core	binding	capacity,	the	Selectivity	Index	value,	
first	described	by	Professor	Thomas	(Arpanaei	et	al.,	2010)	was	used:	






















































MQW	 and	 subsequently	 serially	 diluted	 to	 a	 final	 concentration	 of	 20	 µg/mL	 for	 MO	
(absorption	maxima	 270	 nm	 and	 465	 nm	 (Al-Qaradawi	 et	 al.,	 2002))	 and	 1.073e-5	mol/L	
(absorption	maximum	at	 497	nm	 (Iwunze,	 2010))	 for	 CR	 respectively.	 A	 total	 of	 8	mL	dye	
solution	was	pipetted	into	the	FBR	supplied	with	1	SLM	upward	gas	flow	to	avoid	backflow	of	
the	solution	into	the	gas	supply	line.	After	equilibrating	the	solution	with	the	feed	gas	for	1	

















were	 plasma	 treated	 in	 a	 parallel	 plate	 DBD	 set-up,	 using	 helium	 as	 a	 carrier	 gas.	 The	
adsorbent	samples	were	exposed	to	plasmas	with	input	power	levels	reaching	from	1	W	up	to	
16.6	W	for	treatment	times	up	to	600	s	(2	mm	sample	cake;	650	µLSBV;	3	mm	sample-electrode	
distance).	 Reductions	 of	 pDNA	 (shell)	 and	 BSA	 (core)	 binding	 capacities	 cf.	 an	 untreated	












Plasma	etching	 and	oxidation	of	AEC	 in	 the	DBD	 configuration	 led	 to	 reduction	of	 surface	
pDNA	binding	capacities	up	to	around	80%	for	all	adsorbent	types.		
For	Q	Sepharose	FF,	necessary	conditions	for	pDNA	clearance	above	70%	involve	either	(i)	high	

































Reducing	 the	 distance	 between	 the	 top	 of	 the	 sample	 cake	 and	 the	 top	 electrode	 of	 the	

























formation	 of	 streamers	 (Figure	 3-8).	 Although	 operation	 at	 the	 scale	 used	 in	 this	 work	








reduction	 in	pDNA	binding	 and	9%	 loss	of	 protein	binding)	 from	 static	 binding	 studies.	By	
comparison,	 treatment	of	Q	Hyper	Z	 in	 the	DBD	configuration	gave	a	maximum	selectivity	
















obtained	with	 low	 temperature	 low	 pressure	 plasma	 (Arpanaei	 et	 al.,	 2010)	 in	which	 the	
method	used	to	produced	Q	Hyper	Z	beads	with	selectivity	index	of	2.0	in	static	binding	studies	






the	 similarities	 with	 the	 low	 temperature	 low	 pressure	 etching	 method.	 The	 differences	
between	the	effective	contact	time	of	large	pDNA	molecules	cf.	smaller	proteins	in	dynamic	



















set-up	 was	 hampered	 by	 the	 density	 of	 the	 adsorbents.	Mixing	 via	 gas	 bubbles	 traveling	
















treated	 with	 plasma	 generated	 from	 pure	 oxygen	 tell	 a	 different	 story.	 Plasmid	 DNA	
reductions	 are	 falling	 short	 of	 40%	 while	 core	 binding	 ligands	 were	 attacked	

























In	 accordance	 with	 observations	 outlined	 above,	 SI	 of	 samples	 treated	 with	 pure	 oxygen	





















The	 spectrophotometric	 measurement	 of	 pDNA	 concentration	 in	 liquid	 samples	 by	 UV	
absorbance	(OD260)	relies	on	the	absence	of	contaminants	that	absorb	light	of	the	respective	
wavelength	(Reule,	1976).		
During	 initial	scouting	experiments	 (decolouring	dye	solutions	 in	the	FBR),	 it	was	observed	
that	plasma	 reactions,	 triggered	 in	 situ	proceeded	after	 treatment	had	 finished	 (Appendix		
A-5).	
While	 the	 buffer	 surrounding	 the	 chromatography	media	 during	 the	 plasma	 treatment	 is	
exchanged	 post	 treatment,	 concern	 arose	 whether	 species	 leached	 off	 chromatography	
supports	post	buffer	exchange	(in	storage	tubes)	could	influence	subsequent	analysis	(pDNA	
quantification).	To	ensure	assay	robustness	and	the	absence	of	such	contaminants	(or	their	











































The	 results	 obtained	 confirm	 that	 either,	 the	 reaction	 does	 not	 continue	 leaching	 off	












In	 experiments	 without	 chromatography	 media	 in	 the	 FBR,	 measuring	 the	 conversion	 of	
energy	being	put	into	the	system	to	the	energy	dissipated,	suggests	that	operation	of	the	FBR	




































has	 no	 impact	 on	 the	 conformation	 of	 the	 unbound	 pDNA.	 The	 difference	 in	 brightness	
between	the	two	gel	 lanes	 is	due	to	the	reduced	surface	binding	capacity	of	He-O2	plasma	
etched	 support	 samples	which	 consequently	 yields	 a	higher	 concentration	of	pDNA	 in	 the	
supernatant.	
	
The	 reductions	 of	 pDNA	 binding	 levels	 all	 range	 above	 10%,	 with	 higher	 reduction	 levels	





















One	 of	 the	 factors	 that	 could	 lead	 to	 a	 permanent	 alteration	 of	 the	 support’s	 backbone	
structure	 is	 temperature	 spikes	 in	 close	 proximity	 to	 plasma	 filled	 gas	 bubbles	 (similar	 to	
plasma	 streamers	 observed	 in	 DBD	 configuration).	 These	 (localised)	 high	 temperatures	
occurring	at	elevated	input	power	levels,	melt	the	agarose	for	a	short	period	of	time	prior	to	




the	 beads	 (the	 matrix	 has	 an	 agarose	 content	 of	 6%,	 even	 a	 short	 overheating	 causes	
significant	alteration	to	the	pore	walls	by	either	‘sealing	them	off’	or	‘burying’	ligand	sites	with	
agarose).	 This	 effect,	 as	well	 as	 reduction	 of	 overall	 accessible	 (core)	 binding	 sites	 due	 to	








The	 plasma	 treatment	 to	 etch	 away	 functional	 ligands	 off	 the	 surface	 of	 chromatography	
beads	 is	 a	 gentle	 treatment	without	 the	generation	of	 large	amounts	of	 toxic	by-products	
(Schram,	1987).	During	the	plasma	operation,	the	support	slurry	in	the	reactor	heats	up	over	
time	due	to	the	dissipation	of	energy	in	the	system	(Figure	3-15).	Elevated	temperatures	can	
not	 only	 have	 a	 crucial	 effect	 on	occurring	 plasma	 reactions	 but	 also	 on	 the	 formation	of	
different	ROS	species	(Fridman,	2008).		
	
To	 investigate	 the	 impact,	 elevated	 temperatures	 have	 on	 plasma	 treatment	 of	
Q	 Sepharose	 FF	 media,	 two	 sets	 of	 samples	 were	 treated	 under	 identical	 electronic	















are	depicted	 in	Figure	3-16.	All	 samples	 showed	very	minor	 reductions	of	 their	 core	 (BSA)	
binding	capacities	post	plasma	treatment	in	comparison	to	the	untreated	control	sample	(the	
uncooled	60	min	treatment	showing	the	highest	reduction	of	BSA	binding	capacity	(10.3%)	
with	 all	 other	 samples	 below	 10%).	While	 no	 severe	 BSA	 binding	 capacity	 reduction	 was	
observed	 in	any	of	 the	samples,	 the	reductions	seen	 in	 the	samples	 treated	 in	 the	reactor	







































20,	 40	 and	 60	 min	 treatments,	 respectively)	 coinciding	 with	 reaching	 the	 steady	 state	
temperature	of	the	reactor	around	20°C.		
As	not	all	of	the	surface	charges	have	been	eliminated,	the	ROS	must	have	diffused	into	the	
















An	 overall	 lower	 temperature	 of	 the	 sample	 slurry	 leads	 to	 lower	 losses	 of	 core	 binding	
capacity	however,	this	is	at	the	expense	of	surface	binding	capacity	reduction	(Table	3-1).	
From	 all	 SI	 values	 being	 higher	 for	 samples	 treated	 at	 elevated	 temperatures,	 it	 can	 be	
concluded	that	the	‘savings’	of	core	binding	capacities	seen	with	the	ice-bathed	reactor	do	not	
justify	the	loss	of	surface	reduction	compared	to	the	uncooled	reactor.		








will	prevent	accumulation	of	 further	species	 in	solution	and	the	reaction	chokes	 itself.	The	
presence	 of	 these	 species	 could	 furthermore	 interact	 with	 the	 plasma	 reaction	 itself	 by	
‘poisoning’	the	reaction	due	to	their	high	reactivity.	Interaction	between	the	plasma	species	















media’s	performance	post	 treatment,	 the	overall	 treatment	 time	was	 split	 up	 into	 several	
shorter	intervals	with	buffer	exchange	steps	in	between.	
Rather	than	one	long	treatment	a	‘cascade’	of	intervals	with	overall	constant	treatment	times	














After	 the	 last	 treatment,	 samples	were	 resuspended	 in	 TE	 buffer	 (10	mL	 total	 volume)	 in	
















































especially	 with	 the	 formation	 of	 peroxides	 (ROOH)	 and	 peroxide	 radicals	 (RO2)	 (Fridman,	
2008).	These	and	other	highly	reactive	radicals,	have	various	longevities	in	aqueous	solutions.	
The	FBR	used	 in	 this	 study	 is	effective	 to	etch	 small	batches	of	 chromatography	 supports.	
However,	 scale	 up	 of	 a	 FBR	 that	 requires	 operational	 conditions	 (continuous	 gas	 flow)	 to	
maintain	mixing	 of	 the	 supports	 is	 difficult.	 Other	 designs	 are	 imperative	 for	 larger	 scale	
manufacturing	conditions.		
One	option	to	enhance	the	throughput	of	the	reactor	 is	 to	separate	the	plasma	treatment	
from	the	actual	etching	of	chromatography	media.	 If	 reactive	species	are	stable	enough	 in	
solution,	in	conjuncture	with	a	high	solubility	in	aqueous	solution,	plasma	treatments	of	MQW	
containing	no	chromatography	media	would	offer	several	elegant	solutions:	Plasma	treatment	




In	 order	 to	 explore	whether	 ROS	 retain	 their	 efficacy	 to	modify	 the	 binding	 behaviour	 of	




pipetted	 out.	 The	 MQW	 (7	 mL;	 retaining	 SBV:	 MQW	 ratio	 of	 previous	 experiments)	 was	
treated	in	the	FBR	as	described	in	2.3.5	(14.5kHz;	7	W;	10	min;	gas	flow:	750	mL/min	(flow	
chart	 of	 pure	 helium);	 He-	 O2	 (99.5-	 0.5%)	 premixed	 by	 BOC	 specialty	 gasses)	 with	 the	
exception	of	lacking	supports	in	slurry.	
Due	 to	 the	 volatile	 nature	 of	 the	 experiment,	 two	 sets	 of	 1	 mL	 SBV	 Q	 Sepharose	 FF	
chromatography	 supports	 were	mixed	 separately	 with	 plasma	 treated	MQW	 immediately	
after	the	reactor	was	turned	off	by	pouring	the	contents	of	the	reactor	straight	 into	tubes	













from	 adsorption	 capacities	 displayed	 by	 the	 control	 sample,	 for	 both	 pDNA	 and	 BSA	
adsorption.	 The	 reaction	 requires	 the	 plasma	 species	 to	 adsorb	 onto	 the	 chromatography	
supports	in	order	to	etch	away	and	oxidise	ligands	on	their	surfaces.	Even	after	allowing	the	






































































acetate,	 potassium	 acetate,	 potassium	 chloride)	 during	 cold	 atmospheric	 pressure	 plasma	
treatments	of	hydrogel	AEC	media,	does	not	contribute	to	a	higher	 loss	of	surface	binding	
capacity	 in	 static	 binding	 studies.	 This	 may	 be	 due	 to	 reduced	 electric	 resistance	 and	












behaved	 differently	 before	 and	 after	 plasma	 treatments	 in	 static	 binding	 studies	 across	
batches.	






















beads,	 however	 batch	 2	 and	 3	 would	 even	 after	 a	 sorting	 process	 (eliminating	 the	 non-


































of	 the	 adsorptive	 layer	 is	 largely	 independent	 of	 the	 particle	 diameter	 (neglecting	 the	
miniscule	slope	of	the	linear	fit	through	the	data	points).	The	extend	of	pDNA	binding	into	the	
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media	 show	 non-spherical	 shapes.	 These	
non-uniform	beads	are	of	particular	interest	
with	 regard	 to	 binding	 of	 pDNA	 to	 surface	
regions	that	are	less	accessible	to	convection	
from	 the	 surrounding	media.	To	assess	 the	
extent	 of	 pDNA	 binding	 depth	 to	 these	
‘unconventional’	 surfaces,	 CLSM	 images	 of	
supports	bearing	‘beads	inside	bead’	shapes	
were	 recorded,	 and	 binding	 penetration	
measured	in	the	same	way	as	for	the	outer	
shell	of	the	particles	(Figure	3-26).	
The	 size	 of	 the	 pDNA	 binding	 layer	 in	 the	



















to	 create	 clear	 images	 and	 help	 to	 avoid	 interference	 caused	 by	 autofluorescence	 of	 the	
scaffold	by	allowing	a	reduction	of	excitation.	Due	to	the	use	of	 fluorescent	 labels	without	
overlapping	 excitation/	 emission	 spectra,	 several	 different	 compounds	 can	 be	 visualised	
simultaneously	within	the	same	environment.	
To	visualise	the	binding	properties	of	different	chromatography	media	and	to	localise	regions	








through	 the	 adsorbent	 particles	 was	 obtained	 by	 translation	 of	 the	 confocal	 images	 into	
fluorescence	 intensity	 profiles	 after	 manually	 selecting	 equator	 stacks	 (largest	 diameter	



























Cold	 atmospheric	 pressure	helium	plasma	 (admixed	with	0.5	%	 (v/v)	 oxygen)	was	used	 to	
functionalise	chromatography	supports	by	modifying	the	exteriors	of	Q	Sepharose	FF,	DEAE	
Sepharose	FF	and	EMD	Fractogel	(M)	DEAE	via	plasma	etching	and	oxidation	as	described	in	

































Q	Sepharose	FF	 10	 150	 61.5	 4.8	
Q	Sepharose	FF	 20	 150	 66.3	 (-1.3)	
Q	Sepharose	FF	 10	 300	 67.3	 17.3	
DEAE	Sepharose	FF	 10	 150	 47.5	 6.4	
DEAE	Sepharose	FF	 20	 150	 62.4	 18.8	
DEAE	Sepharose	FF	 10	 300	 61.3	 26.1	
EMD	Fractogel	
DEAE	
10	 150	 55.8	 2.9	
EMD	Fractogel	
DEAE	
20	 150	 74.1	 17.9	
EMD	Fractogel	
DEAE	








Plasma	etching	of	Q	Sepharose	FF	yielded	significant	 reduction	of	 shell	binding	capacity	 in	
static	pDNA	binding	studies	of	up	to	67%	for	the	300	s,	10	V	sample	(Table	3-3).	
When	 comparing	 the	 data	 to	 reduction	 of	 pDNA	 fluorescence	 intensity	 within	 the	 same	
sample	(both	peak	intensity	and	average	peak	area),	pDNA	binding	capacity	is	reduced	less	
(39.1%	and	32.5%,	respectively).	So,	although	the	trends	of	the	plasma	parameters	for	the	


























































































































































The	 shape	 of	 the	 pDNA	 distribution	 curve	 showcases	 a	 behaviour	 similar	 to	 the	 protein	























Following	 up	 on	 the	 light	micrographs	 of	 plasma	 treated	 chromatography	 supports	 taken	
alongside	 CLSM	 images,	 to	 evaluate	 the	 impact	 the	 plasma	 treatment	 has	 on	 the	 visual	
appearance	of	the	structural	 integrity	of	Q	Sepharose	FF	adsorbent	material,	ESEM	images	
were	taken	as	described	in	2.3.11.	
As	mentioned	previously,	 some	Q	 Sepharose	 FF	beads	 show	 ‘imperfections’	 both	on	 their	
surface	as	well	as	inside	the	internal	core	structure	of	the	beads	(Figure	3-32).	Imperfections	
in	this	 regard	were	defined	as	particles	without	a	smooth	surface	and/	or	spherical	shape.	









open	 access	 to	 the	 core	 structure	 of	 the	 support,	 as	well	 as	 ‘bead-inside-bead’	 structures	
similar	to	those	observed	in	untreated	Q	Sepharose	FF.	














however,	 to	 the	 authors	 knowledge,	 little	 work	 on	 visual	 depiction	 of	 chromatography	





























ultimately	 resulting	 in	 peak	broadening/	 tailing	 (Rouessac	 et	 al.,	 2000;	Ninfa	 et	 al.,	 2010).	
Another	problem	in	flow	through	chromatography	operations	is	column	fouling.	The	use	of	













more	easily	 accessible	 surfaces,	 leaving	 functional	 groups	 in	hard	 to	 access	 regions	of	 the	
particles	untouched.	
However,	 in	 frontal	 loading	 chromatography	 applications,	 pDNA	 will	 diffuse	 into	 these	
crevices	and	imperfections	and	bind	to	the	ligands	that	have	not	been	etched	away	by	plasma	
radicals.	These	remaining	binding	sites	will	get	supersaturated	with	pDNA	due	to	their	strong	
negative	 charges,	 distributed	 evenly	 all	 over	 the	molecule.	When	 granted	 enough	 time	 to	






SEM	 image	 analysis	 qualitatively	 showed	 the	 presence	 of	 imperfect	 beads	 and	 raised	 the	
question	to	what	quantitative	scope	they	are	part	of	support	populations.	To	get	an	overview	
of	the	magnitude	of	imperfections	in	large	populations	of	different	chromatography	media,	












































































































Comparing	 the	 visual	 integrity	 of	 plasma	 treated	 supports	 to	 untreated	 control	 beads,	 no	
difference	can	be	observed	with	confidence	intervals	of	the	distributions	overlapping.		
Previously	 it	 was	 suggested	 that	 the	 high	 loss	 of	 core	 binding	 capacity	 in	 oxygen	 plasma	
treated	 support	 samples	 could	be	due	 to	plasma	puncturing	holes	 into	 the	 surface	of	 the	
beads,	reducing	the	overall	core	binding	volume	(Olszewski	et	al.,	2013).	It	must	be	concluded,	
that	 previously	 recorded	 SEM	 images	 were	 not	 representative	 of	 the	 phenomena	 but	
singularities	that	occur	in	all	Sepharose	FF	based	media.	
Capto	 Core	 700	 stands	 out	 from	 other	 Sepharose	 based	 media	 with	 only	 2.6%	 of	 beads	
showing	major	imperfections.	Being	a	highly	specialised	media	(and	at	a	retail	price	of	more	





the	visual	appearance	of	 the	particles	 (however,	 the	media	 is	still	unsuitable	based	on	the	
presence	of	diffusive	pores,	granting	pDNA	binding	throughout	the	media.	
3.3.2.16.	CLSM	analysis	of	‘imperfect’	supports	
SEM	 images	as	well	 as	quantitative	 light	microscopic	analysis	of	different	 chromatography	
support	media	have	shown	that	large	portions	of	the	populations	have	visual	imperfections	
on	their	surfaces.	These	imperfections	range	from	minor	visual	impairments	(dents,	cracks	on	
the	 surface)	 to	 major	 ‘disfigurements’.	 Comparing	 images	 of	 plasma	 treated	 supports	 to	
respective	images	of	untreated	control	samples	yielded	that	these	imperfections	are	not,	as	
previously	 assumed	 a	 result	 of	 the	 plasma	 treatment	 process	 but	 find	 their	 origin	 in	 the	
manufacturing	process	of	the	media.	
The	 static	 binding	 capacities	 of	 the	media	was	 assessed,	 but	 static	 binding	 capacities	 of	 a	
media	as	a	whole	does	not	explain	whether	the	presence	of	imperfections	has	an	impact	on	
the	chromatographic	performance/	binding	capacity	of	the	media	on	a	single	bead	level.	









media,	 CLSM	 stack	 images	 of	 said	 imperfect	 beads	 were	 recorded	 as	 described	 in	 2.3.12	
focussing	on	imperfect	single	beads.	
















The	respective	 intensity	profiles	show	that	significantly	more	pDNA	 is	adsorbed	within	 the	
imperfections	than	on	the	smooth	(outer)	surface	of	the	media.		
The	 plasma	 treatment	 of	 chromatography	 supports	 is	 an	 efficient	 way	 to	 modify	 the	
functionality	 of	 the	beads	 on	 the	 surface	of	 the	media,	 however	 the	modification	 can,	 by	





















ligands	in	the	area:	 𝑉 = 43𝜋	(𝑟Y − 𝑟JY)	
Where;	 Vb		 is	core	binding	volume	of	the	bead		
	 	 rb	 is	the	radius	of	the	bead	













media,	 will	 not	 only	 reduce	 the	 core	 binding	 capacity,	 the	 shell	 binding	 is	 also	 altered	 in	
comparison	to	a	spherical	particle	(Figure	3-40;	B):	𝐴 = 4𝜋	𝑟 − 2𝜋	𝑟ℎ + 2𝜋	𝑟J𝑥		
With:	 	 Ab		 is	the	binding	surface	of	the	bead	
	 	 rb	 is	the	radius	of	the	bead	
	 	 ri	 is	the	radius	of	a	(spherical)	imperfection	
	 	 h		 height	of	the	missing	cap	of	the	bead	




CLSM	 images	 of	 imperfect	 cold	 atmospheric	 pressure	 helium-oxygen	 gas	 plasma	 treated	
chromatography	 supports	 (Figure	 3-38	 to	 Figure	 3-42)	 show	 that	 the	 plasma	 is	 unable	 to	
significantly	 modify	 the	 surfaces	 occurring	 within	 the	 imperfections	 (both	 Q	 and	 DEAE	
Sepharose	 FF).	 The	 reactive	 plasma	 species	 cannot	 access	 the	 crevices	 created	 by	










The	 BSA	 intensities	 remain	 similar	 throughout	 the	 bead	 with	 the	 exception	 that	 in	 close	
proximity	to	the	imperfection,	BSA	fluorescence	is	higher	than	in	the	centre	of	the	bead.		
As	 stated	previously,	 the	 fluorescence	 intensity	 on	 the	 surface	of	 a	 sample	will	 always	be	
(slightly)	higher	 than	on	 the	bottom	or	 the	bulk	of	 a	 sample	as	 the	photons	need	 to	pass	
through	media	of	different	refractive	indices.	

















During	 the	 manufacturing	 process	 of	 Sepharose	 based	 chromatography	 media,	 molten	
agarose	droplets	are	being	cooled	down	to	induce	agarose	gelling.	During	this	process,	the	
surface	tension	of	the	droplets	influences	the	agarose	content,	leading	to	a	slightly	different	
agarose	 content	 of	 the	 smaller	 ‘beads-inside-a-bead’	 imperfections	 in	 comparison	 to	 the	
larger	 (main)	 particle.	 The	parameters	 controlling	 the	 cooling	of	 the	media	 are	difficult	 to	
control	and	so	it	is	likely	that	batch	to	batch	variations	of	a	final	product	can	lead	to	different	
agarose	contents	within	the	same	bead.		
In	 addition	 to	 the	 inability	 to	 etch	 binding	 ligands	 off	 the	 surfaces	 of	 the	 beads,	 a	 higher	
amount	 of	 pDNA	 binds	 within	 the	 grooves	 of	 the	 surfaces	 due	 to	 supersaturation	 of	 the	
remaining	 accessible	 binding	 sites	 as	 well	 as	 trapping	molecules	 inside	 eddies	 of	 caverns	






















Sieving	 of	 existent	 base	media	 is	 not	 only	 hard	 to	 implement	 but	 also	 lacks	 the	 scope	 of	
scalability.	 Swapping	 Sepharose	 FF	 media	 for	 a	 starting	 media	 providing	 better	 optical	
properties	 could	 lead	 to	 great	 improvements	 of	 media	 performance.	 Capto	 media,	 for	
example,	has	shown	to	be	superior	over	Sepharose	FF	in	terms	of	level	of	imperfect	supports.	











chemical	 structure	 of	 the	 outside	 of	 chromatography	 supports	 targeted	 for	 nanoplex	
purification.		
ToF-SIMS	 has	 proven	 to	 be	 useful	 as	 a	 surface	 analysis	 technique	 for	 the	 chemical	
characterization	of	polymer	surfaces	(Vickerman	et	al.,	2001).	In	order	to	assess	modifications	
to	the	surface,	happening	during	plasma	etching	of	chromatography	supports,	the	technique	
was	 used	 for	 the	 qualitative	 and	 semi-quantitative	 analysis	 of	 surface	 compositions	 of	
Q	Sepharose	FF	media	prior	and	post	cold	atmospheric	pressure	plasma	treatment	(both	pure	
oxygen	as	well	as	helium-oxygen	admixed	(99.5%-	0.5%)	gas	plasma	samples).		
The	 resulting	 mass	 spectra	 contain	 a	 large	 number	 of	 peaks	 corresponding	 to	 various	
compounds,	 which	 by	 evaluating	 the	 masses	 associated	 to	 the	 signals,	 can	 lead	 to	 their	
identification	from	the	molecular	ion	of	the	sample	or	its	fragments	(Belu	et	al.,	2003).	
Chromatography	 support	 samples	 were	 dried	 as	 described	 in	 2.3.10.	 All	 samples	 were	
mounted	on	carbon	tape	before	using	a	ToF-SIMS	5	(IonToF	Münster	Germany)	equipped	with	
a	Bi(3+)	source	for	the	sample	analysis.	
For	 each	 sample,	 duplicate	 spectra,	 both	 negative	 and	
positive	 (area	 of	 analysis	 20x20	 µm	 (Figure	 3-43)	 were	
recorded.	 Due	 to	 the	 volume	 of	 data	 recorded	 for	 each	
sample,	Matlab	 (R2017A)	was	used	 for	data	processing	as	
well	as	graphical	depiction	of	results.	
All	 analysed	media	 are	based	on	 Sepharose	6	 FF	with	 the	








































15.02	 CH3	 Sepharose	 60.09	 C3H10N	 Ligand	
27.02	 C2H3	 Sepharose	 69.03	 C4H5O	 Sepharose	
29	 CHO	 Sepharose	 71.01	 C3H3O2	 Sepharose	
29.04	 C2H5	 Sepharose	 73.03	 C3H5O2	 Sepharose	
31.02	 CH3O	 Sepharose	 81.04	 C5H5O	 Sepharose	
39.02	 C3H3	 Sepharose	 85.03	 C4H5O2	 Sepharose	
41.04	 C3H5	 Sepharose	 97.03	 C5H5O2	 Sepharose	
42.03	 C2H4N	 Ligand	 100.12	 C6H14N	 Ligand	
43.02	 C2H3O	 Sepharose	 102.09	 C5H12NO	 Ligand	
43.06	 C3H7	 Sepharose	 116.11	 C6H14NO	 Ligand	
45.03	 C2H5O	 Sepharose	 132.1	 C6H14NO2	 Ligand	
53.04	 C4H5	 Sepharose	 174.15	 C9H20NO2	 Ligand	
55.02	 C3H3O	 Sepharose	 176.13	 C8H18NO3	 Ligand	
55.06	 C4H7	 Sepharose	 190.15	 C9H20NO3	 Ligand	
57.04	 C3H5O	 Sepharose	 206.14	 C9H20NO4	 Ligand	
58.07	 C3H8N	 Ligand	 234.17	 C11H24NO4	 Ligand	
59.07	 C3H9N	 Ligand	 	 	 	
	
The	fingerprint	pattern	of	the	positive	ion	spectrum	of	Q	Sepharose	FF	is	hence	expected	to	
be	 similar	 to	 its	 backbone	matrix	 structure	 Sepharose	 6	 FF,	with	 additional	 ligand	 specific	
peaks	 characterizing	 the	 spectrum.	 Most	 of	 the	 peaks	 associated	 with	 the	 Q	 ligand	













studies	 however	 confirm	 that	 the	 ligand	 is	 homogenously	 distributed	 across	 the	 beads	
(Johansson	et	al.,	2004).	
The	highest	peak	of	the	spectrum	is	the	first	ligand	associated	fragment	at	58.07	m/z	(C3H8N).	






Both	 Sepharose	 6	 FF	 and	Q	 Sepharose	 FF	 have	 very	 characteristic	 ‘fingerprint	 spectra’	 of	
respective	ToF-SIMS	peaks	 (Figure	3-45	 )	with	 the	 Sepharose	6	 FF	 ‘fingerprint’	 depicting	 a	
surface	of	 a	media	exclusively	made	of	 agarose,	while	
the	Q	Sepharose	FF	‘fingerprint’	illustrates	the	impact	of	
the	 presence	 of	 Q	 ligands	 has	 on	 the	 spectrum.	 To	
evaluate	the	effect	of	cold	atmospheric	pressure	plasma	
treatments	 on	 the	 external	 (chemical)	 surface	
composition	 of	 Q	 Sepharose	 FF	 chromatography	
supports,	 their	 recorded	 positive	 ToF-SIMS	 spectra	
(Figure	 3-37)	were	 compared	 to	 fingerprint	 spectra	 of	
untreated	control	media	(Figure	3-38).		
To	 assess	 the	 impact,	 plasma	 treatments	 have	 on	 the	
ToF-SIMS	 spectra	 of	 Q	 Sepharose	 FF	 supports,	 two	 different	 conditions-	 He-	 O2	 admixed	
(99.5%-	0.5%)	gas	plasma	(20	V;	150	s;	12.5%	SBV)	and	pure	oxygen	gas	plasma	treated	(15	V;	
150	s;	18.75%	SBV)	samples	were	analysed.		
Both	 samples	 showed	 reductions	of	 surface	 (66.3%	and	44.2%	 reduction	of	 pDNA	binding	








































































































































































































the	 window	 of	 analysis	 hits	 one	 of	 these	 islands,	 lesser	 etched	 areas	 will	 bear	 a	 strong	
resemblance	to	the	Q	Sepharose	FF	spectra,	rather	than	Sepharose	6	FF.	
	
Spectrum	 of	 oxygen	 gas	 plasma	 treated	 sample	 resembles	 the	 ‘fingerprint’	 pattern	 of	 Q	
Sepharose	FF.	Similarly,	to	the	second	helium	gas	plasma	spectrum,	all	ligand	associated	peaks	
















































employed	 to	 selectively	 modify	 the	 exteriors	 of	 chromatography	 supports,	 generating	
bilayered	 SEC-IEC	 materials	 with	 reduced	 surface	 pDNA	 binding.	 Although	 plasma	
technologies	are	normally	known	to	act	at	the	nanoscale,	the	presented	results	suggest	that	




25%	 loss	 of	 BSA	 binding.	 Selectivity	 indices	 (up	 to	 2.5)	 seen	 for	 Q	 Hyper	 Z	 in	 the	 DBD	
configuration	compare	favourably	to	results	seen	in	previous	studies	with	low	temperature	
low	pressure	plasma	 treatments	 (Arpanaei	 et	 al.,	 2010)	 (selectivity	 indices	up	 to	2.0).	 The	
formation	of	plasma	streamers,	observed	during	DBD	operation,	could	 lead	 to	 issues	 from	
inconsistent	 treatment	 and	 localised	 support	 damage	 when	 operating	 at	 larger	 scale,	 a	
problem	 that	 can	 be	 avoided	 by	 the	 use	 of	 fluidised	 bed	 plasma	 treatment	 using	 He-O2	
bubbles.		
Fluidised	bed	plasma	treatment	was	shown	to	be	suitable	for	treating	soft	hydrogel	materials	
such	 as	 Q	 Sepharose	 FF	 and	 DEAE	 Sepharose	 FF	 to	 produce	 SEC-IEC	 supports	 with	 high	
selectivity	indices	(up	to	3.0,	corresponding	to	66%	loss	of	pDNA	binding	in	exchange	for	0%	
loss	of	BSA	binding).	These	results	compare	well	with	methods	used	for	‘bottom-up’	synthesis	












population	 in	 agarose	 based	media.	 The	 unsmooth	 fissures/	 crevices	 on	 particle	 surfaces	
hinder	the	elimination	of	ligands	within	said	imperfections,	due	to	the	short-lived	nature	of	




residual	 pDNA	 binding	 is	 limited	 to	 binding	 islands	 with	 residual	 Q	 ligands.	 The	 chemical	
composition	 on	 the	 smooth	 surface	 of	 supports	 resembles	 the	 one	 of	 pure	 agarose,	
confirming	 that	 the	 plasma	 reaction	 selectively	 etches	 the	 ligands	 over	 the	 stationary	
backbone	structure.	
Underwater	 plasma	 treatment	 offers	 real	 promise	 for	 converting	 mono-functional	






of	 established	manufacturing	 processes	 for	 beaded	 chromatography	materials	with	 a	 cold	
atmospheric	pressure	plasma	modification	stage,	could	allow	these	materials	to	be	converted	
into	layered	varieties	through	addition	of	a	single	cost-effective	step.	
The	 success	 of	 cold	 atmospheric	 plasma	 treatment	 for	 creating	 SEC-IEC	 chromatography	
supports	 indicates	a	need	for	 further	research	 in	 this	area.	 It	 is	also	 likely	 that	 larger-scale	
plasma	treatment	using	an	adapted	fluidised	bed	set-up	would	allow	estimates	of	costs	of	









Bilayered	 chromatography	 supports	were	manufactured	 in	 a	bottom-up	approach	 via	AGE	






while	 addressing	 the	 limitations	 of	 the	 technique	with	 regards	 to	 the	 reduction	 of	 pDNA	
binding	capacity	in	comparison	to	unmodified	control	media.	It	was	found	that	the	quality	of	
the	 final	 product	 is	 strongly	 dependent	 on	 the	 starting	 SEC	 chromatography	media,	 with	
flawed	support	beads	binding	pDNA	after	modification.	These	imperfections	at	the	surface	of	










mediated	 immunity)	 response	 (Wolff	 et	 al.,	 1990).	 Plasmid	DNA	vaccine	production	offers	




Gene	 therapy	 uses	 genes	 as	 treatment	 for	 genetic	 defects	 and	 acquired	 diseases	 such	 as	
cancer	and	viral	diseases	(Abdulrahman	et	al.,	2018).	




such	 as	 naked	 pDNA.	 Other	 means	 of	 application	 such	 as	 viral	 vectors	 exist	 and	 are	 still	
commonly	 used	 in	 clinical	 trials	 but	 pDNA	 is	 considered	 safer	 and	 expected	 to	 be	 easier	
produced	on	a	large	scale	at	reasonable	cost	(Ginn	et	al.,	2013).	However,	low	transfection	
efficiencies	 of	 plasmid-based	 vectors	 do	 make	 large	 dosages	 mandatory	 (Ferreira	 et	 al.,	
2000b),	 raising	 the	 need	 for	 large	 quantities	 of	 highly	 pure	 pDNA	 formulations	 and	





still	 the	go-to	method	 for	nanoplex	purification	 (Xenopoulos	 et	al.,	2014).	On	a	 laboratory	
scale,	purification	of	pDNA	is	generally	viewed	as	a	simple	procedure,	especially	considering	



















charge	 distribution	 on	 the	 surface	 (Ghanem	 et	 al.,	 2013).	 These	 negative	 charges	 interact	
locally	 with	 ligands	 on	 stationary	 phases	 and	 are	 consecutively	 eluted	 by	 applying	 a	 salt	
gradient.	The	charge	density	is	closely	related	to	chain	length	due	to	the	amount	of	phosphate	
groups	 in	 the	molecule	and	consequently	 the	 sc	 isoform	 interacts	more	 strongly	with	AEC	
ligands	than	the	oc	isoform,	eluting	at	lower	salt	molarity	(Quaak	et	al.,	2009).	












Several	 research	 attempts	 have	 been	 undertaken	 to	 circumvent	 these	 drawbacks	 by	
enhancing	the	low	binding.	Reducing	the	radius	of	gyration	of	pDNA	molecules	via	addition	of	
compaction	 agents	 shrinks	 pDNA	 molecules	 and	 allows	 for	 deeper	 pore	 penetration,	
enhancing	pDNA	binding	capacity	by	up	to	40%	(Murphy,	2003).	
The	use	of	 perfusive	media	 allows	pDNA	molecules	 to	 enter	 supports	 via	 larger	 perfusion	








surfaces	of	adsorbents.	 In	conjuncture	with	 reduction	of	particle	 size	 for	EBA	applications,	
these	supports	were	found	to	enhance	pDNA	binding	capacity	25	to	70	fold.	(Theodossiou	et	
al.,	2001).	
Enhanced	 binding	 capacity	 via	 size	 reduction	 of	 supports	 yields	 to	 the	 low	 capacities	 of	
classical	supports,	accepting	the	restriction	of	pDNA	binding	to	the	supports	surfaces	alone.	
These	 small	 beads	 have	 however,	 a	 larger	 overall	 surface	 area.	 Issues	 associated	 with	
increased	back	pressure	are	partially	circumvented	by	choosing	a	non-porous	stationary	phase	
(Tiainen	 et	 al.,	 2007d).	 However,	 enhanced	 flow	 velocities	 cause	 concern	 for	 pDNA	
degradation	as	a	result	of	higher	shear	stresses	(Carlson	et	al.,	1995;	Levy	et	al.,	1999).	








Each	 applied	 unit	 operation	 in	 the	 purification	 process	 does	 have	 its	 own	 yield	 and	
consequently	a	margin	of	product	 loss.	With	pDNA	single	 step	 recovery	 rates	beyond	85%	
being	considered	economically	viable	 (Abdulrahman	et	al.,	2018),	 the	appeal	of	combining	







positive	 charge	 properties	 on	 the	 inside	 of	 the	 support,	 while	 an	 inert	 exterior	 prevents	
binding	of	pDNA	to	the	surface	of	the	beads.	
The	 principle	 of	 bilayered	 separation	 media	 with	 a	 core-shell	 design	 conveys	 numerous	
advantages	in	HPLC	applications,	like	processing	speed	and	resolution	(de	Faria	et	al.,	2017).	
With	 commercial	 media	 of	 this	 type	 becoming	 more	 readily	 available	 for	 large	 scale	
purification	of	VLPs,	this	design	also	offers	attractive	possibilities	for	challenging	separations	




reaction	 of	 limited	 amounts	 of	 bromine	 (reactant)	 with	 double	 bonds,	 homogeneously	











the	 applied	method	 in	 order	 to	 accommodate	 both	 the	 elimination	 of	 all	 surface	 ligands,	
whilst	also	keeping	the	shell	as	thin	as	possible	to	compromise	as	little	as	possible	on	overall	
binding	 capacity	 (30%	 loss	 of	 core	 binding	 capacity	 cf.	 fully	 Q	 functionalized	 supports	 in	
Gustavsson’s	initial	study).	Controlling	the	partial	bromination	step	is	hence	key	to	achieve	a	
homogenous,	thin	shell.		
During	 partial	 bromination	 the	 high	 reactivity	 of	 bromine	 is	 of	 particular	 importance;	 low	











commercially	 available	 Sepharose	CL-6B	 SEC	media	was	utilised	 as	 a	 starting	material	 and	
chemical	functionality	was	built	up	in	the	supports	via	an	adapted	5-step	protocol	(Gustavsson	

















Some	 of	 the	 conducted	 experiments	 do	 however	 require	 more	 explanation	 in	 regard	 to	
specific	 parameters,	 as	 Chapter	 2	 only	 describes	 their	 implementation.	 When	 further	
information	 is	 essential,	 it	 is	 given	 in	 the	 respective	 sections	 to	 aid	 readability	 and	
understanding	of	their	processes.	
Methods	describing	experiments	that	are	exclusive	to	this	chapter	are	listed	below.	
To	 avoid	 repetition,	 a	 comprehensive	 list	 covering	 all	 materials	 and	 equipment	 used	 to	
























shaken	 until	 the	 reaction	 had	 finished	 (discoloration	 of	 solution)	 and	 supports	 repeatedly	
washed	in	MQW.	
Prior	 to	 suspending	 support	 beads	 in	 sucrose	 solutions,	 the	 rheological	 behaviour	 of	 the	
solutions	 was	 assessed.	 An	 Advanced	 Rheometer	 AR1000	 (TA	 Instruments;	 New	 Castle;	
Delaware;	USA)	equipped	with	a	2°	angle,	40	mm	stainless	steel	cone	shaped	geometry	was	
















8	mL	 (SBV)	of	 supports	were	 rehydrated	 in	3.48	mL	MQW	and	0.39	g	sodium	acetate	was	






















80	µL	 of	 chromatography	 supports	 slurry	 in	MQW	were	pipetted	onto	 a	microscope	 slide	
(VWR	VistaVision	Microscope	Slides,	VWR	 International,	UK)	and	covered	with	a	cover	slip	
(VWR	Micro	 Cover	Glasses),	 carefully	 avoiding	 the	 formation	 of	 air	 bubble	 inclusions.	 The	
sample	was	 then	analysed	 in	an	Olympus	BX50	Light	microscope	using	4x,	10x,	20x	or	40x	
magnification	 respectively.	 For	 images	 taken	 with	 a	 100x	 magnification,	 a	 droplet	 of	
immersion	oil	(Sigma	Aldrich)	was	used	to	bridge	the	gap	between	lens	and	cover	slide.	
































Crafting	 bilayered	 SEC-AEC	 supports	 following	 the	 bottom	 up	 approach	 described	 by	
Gustavsson	involves	a	total	of	five	working	steps	(Gustavsson	et	al.,	2004);	(i)	introduction	of	
allyl	 groups	 throughout	 the	 stationary	 phase	 of	 Sepharose	 CL-6B	 by	 reacting	 AGE	 with	
hydroxyl	groups	on	the	backbone	of	the	agarose	based	media;	 (ii)	partial	bromination	of	a	




partial	 bromination	 involves	 several	 non-equilibrium	 transport	 phenomena,	 which	 have	
crucial	impact	on	the	shape	and	size	of	the	inert	shell.		






Addition	 of	 viscosity	 enhancing	 reagents	 (such	 as	 sucrose)	 offers	 control	 over	 the	 partial	
bromination	by	balancing	reaction	and	diffusion	rates.		
Among	 other	 parameters	 influencing	 the	 partial	 bromination	 step	 (reaction	 temperature,	
addition	of	adjuvants,	etc.),	 this	 study	 focusses	on	 the	degree	of	partial	bromination	all	at	
different	viscosities	adjusted	via	sucrose	addition	(0-	80%).	
Three	sets	of	bilayered	support	samples	were	manufactured,	featuring	single	10%	and	20%	of	













up	 to	 80%. Sucrose	 contents	 exceeding	 64%	 however,	 led	 to	 a	 decline	 in	 pDNA	 binding	
reduction	in	both	single	10	and	20%	partial	bromination.		
The	results	suggest	that	the	viscosity	is	too	high,	preventing	effective	transport	of	bromine	to	









that	 double	 partial	 bromination	 of	 10%	 led	 to	 reductions	 of	 ~30%	 of	 allyl	 groups.	 Higher	
reduction	 levels	 than	 the	 targeted	10+10%	were	associated	 to	difficulties	 in	pipetting	very	
small	 sample	 volumes	 and	 immediate	 mixing	 of	 bromine.	 The	 resulting	 preparation	 can	
however	be	taken	as	a	30%	partial	bromination	via	repetitive	incremental	reaction.	
Consistently	 high	 pDNA	 binding	 reductions	 >70%	 were	 found	 for	 all	 VE-RDB	 double	 10%	
















around	 20%,	 unaffected	 by	 the	 bilayer	 creation	 at	 the	 surface	 cannot	 be	 overcome	 by	
additional	bromination	and	is	independent	of	viscosity	enhancing	reagents.	This	effect	cannot	
be	explained	by	means	of	static	binding	capacity	reductions	alone.	
To	 evaluate	 the	 effect	 of	 residual	 pDNA	 binding	 (on	 the	 surface?),	 the	 supports	 were	
investigated	further	using	visualization	techniques	(light	microscopy	and	CLSM	respectively).		



















































the	 strong	 anion-exchange	 ligand	 Q	 via	 AGE-activation,	 directly	 followed	 by	 excess	
bromination	and	ligand	coupling.		
CLSM	 images	 of	 control	 supports	 show	 a	 bright	 green	 halo	 (SYTO-9	 fluorescently	 tagged	
pDNA)	 surrounding	 a	 red	 core	 (Cy5	 labelled	 BSA).	 The	 pDNA	 is	 too	 large	 (26.88	 kbp)	 to	
penetrate	 through	 the	 outer	 micrometres	 of	 the	 porous	 bead	 and	 bind	 to	 ligands,	 lining	
internal	pores	of	the	supports.	Binding	is	hence	limited	to	the	surface	of	the	supports.	BSA	is	

























binding	 capacity-	 based	 on	 volume	 weighted	 mean	 D[4.3]=	 110.81	 µm	 (Figure	 4-9)).	 The	
demarcation	zone	surrounding	the	core	is	of	homogenous	thickness.		
Sucrose	slows	down	the	diffusion	of	bromine	into	the	core	and	hence	condenses	the	charge	





Whilst	 addition	 of	 sucrose	 reduces	 the	 rate	 of	 bromine	 hydrolysis	 in	 aqueous	 solutions	
(Joseph,	2018-	 in	preparation),	 the	effect	 is	outweighed	by	a	slower	 rate	of	bromine	mass	
transfer	from	the	bulk	solution	to	the	supports.	This	reduces	the	overall	amount	of	bromine	



























































































































































the	 overall	 population	 and	 subsequently	 are	 responsible	 for	 residual	 pDNA	 binding	 post	
treatment.	To	assess	the	degree	to	which	the	presence	of	misshaped	supports	within	a	sample	
population	 contribute	 to	 remaining	 pDNA	 binding	 of	 restricted	 access	 media,	 light	
micrographs	of	a	large	population	of	supports	have	been	collected	and	evaluated.	For	each	
analysed	SEC	media	(fully	derivatised	media	based	on	Sepharose	CL-6B	used	as	control	media	
for	 static	 binding	 studies	 and	 CLSM;	 a	 different	 batch	 of	 the	 same	 media;	 10%	 partially	
brominated	supports	(64%	sucrose	addition);	Superose	6;	Superose	12	and	Sepharose	6	FF)	a	
statistically	relevant	sample	size	of	particles	was	imaged	and	grading	of	visual	integrity	of	each	



































of	 the	 supports,	 all	 three	 media	 are	 expected	 to	 yield	 better	 SI	 when	 crafted	 into	 RAM	
following	a	similar	protocol.		
The	population	of	 ‘red’	 supports	 in	 the	second	Sepharose	CL-6B	batch,	was	with	3%,	a	 lot	
smaller	than	the	batch	used	for	crafting	bilayered	media.	This	highlights	the	importance	of	























However,	 large	 surface	 imperfections	 including	macropores,	 deep	 fissures,	 ‘bead-inside-a-








presence	 of	 such	 imperfect	 chromatography	 supports.	 The	 amount	 of	 flawed	 supports	 is	
hereby	strongly	dependant	on	the	respective	batch	and	type	of	SEC	starting	media	used.		
While	 on	 a	 laboratory	 scale,	 a	 visual	 inspection/	 sieving	 of	 imperfect	 beads	 would	 be	
conceivable,	it	is	not	a	serious	consideration	for	industrial	production	scale.	This	emphasises	
the	 importance	 of	 starting	media	 selection,	 as	 well	 as	 a	 visual	 batch-to-batch	 analysis	 of	
support	surface	integrity.	
Quantitative	 analysis	 of	 CLSM	 fluorescence	 intensity	 traces	 indicate	 that	 pDNA	 binding	 to	
remaining	 binding	 sites	within	 the	 groves	 of	 imperfections	 are	 elevated	 in	 comparison	 to	
	 -	177	-	
smooth	 surfaces	 of	 control	media.	 In	 static	 binding	 studies,	 the	 10%	 partially	 brominated	










the	manufacturing	 of	 RAM	 via	 the	 AGE-activation,	 partial	 bromination	 route,	 a	 couple	 of	
improvements	are	to	be	considered	when	applying	the	technique	for	future	work.	











The	dependence	of	 the	 final	product	on	 the	visual	 integrity	of	 the	 starting	media	 calls	 for	
application	 of	 the	 technique	 to	 use	 ‘better’	 SEC	 resins.	 These	 could	 either	 be	 crafted	 to	
purpose	by	changing	the	existing	production	protocols	in	a	collaboration	with	a	manufacturer	






By	 using	 the	 ‘better’	 base	matrix	 Superose	 6	 over	 the	 ‘more	 flawed’	 Sepharose	 CL-6B,	 SI	
indices	of	up	to	370	could	be	achieved,	confirming	the	conclusions	presented	in	this	study,	










the	 intermediate	 purification	 of	 large	 nanoplex	 biomolecules,	 such	 as	 VLPs.	 Although	 the	
manufacturer	suggests	reducing	nucleic	acid	concentrations	in	the	feed	prior	to	loading	it	onto	





























The	media	 is	 available	 in	 different	 packing	 formats	 (GE	 Healthcare,	 2018b):	 prepacked	 as	
HiScreen	 columns	 optimised	 for	 method	 and	 process	 development,	 HiTrap	 columns	 for	





























contaminants	 unimportant.	 This	 is	 crucial	 given	 the	 vigorous	 elution	 conditions	 that	 are	
necessary	to	reverse	the	ligands	strong	interactions	post	loading.	
Since	 its	release,	CC700	media	has	been	successfully	used	 in	various	DSP	strategies	for	the	







The	 route	 of	 manufacturing	 of	 CC700	 is	 proprietary,	 however	 several	 patents	 suggest	 a	
















Cold	atmospheric	pressure	plasma	 treatment	 in	a	FBR,	 for	 the	 functionalisation	of	beaded	





























solution).	 Throughout	 chromatography	 runs,	 UV260,	 UV280	 absorbance	 as	 well	 as	 pH	 and	




buffer	 of	 frontal	 chromatographic	 experiments.	 The	 beaded	 supports	 (75	 µl	 SBV)	 were	
incubated	with	1.5	mL	of	0.5	mg/mL	baker’s	yeast	RNA	(S.	cerevisiae)	for	30	min	on	a	blood	









CC700	 aims	 at	 the	 intermediate	 purification	 of	 viruses	 and	 other	 large	 biomolecules.	 The	
manufacturer	suggests	to	reduce	the	amount	of	NA	in	the	feedstock	as	“high	levels	of	DNA	
and	RNA	can,	in	some	cases	impair	the	performance	of	CC700”	(GE	Healthcare,	2012).	
The	shell	of	 the	beaded	media	 is,	according	to	the	manufacturer,	devoid	of	 ligands	on	the	
outside	of	the	particles	and	is	permeable	only	by	moieties	<700	kDa,	such	as	RNA	or	HCP	(GE	
Healthcare,	2018b).	These	properties	should	make	the	media	ideal	for	capturing	pDNA	from	
crude	E.	 coli	 feedstocks,	 if	 the	 plasmid	 is	 large	 enough	 to	 not	 enter	 and	 bind	 to	 the	 core	
alongside	contaminants	in	the	lysate,	such	as	RNA	and	HCP.	

















Looking	 at	 the	 gel	 electrophoresis	 image	 of	 the	 chromatographic	 fractions,	 several	 points	
stand	 out;	 the	 absence	 of	 RNA	molecules	 in	 loading	 fractions	 indicate	 that	 breakthrough	

















Residual	 binding	 of	NA	 to	 the	media	 after	 elution	 suggests	 that	NA,	 bound	 to	 octylamine	
ligands,	 cannot	 be	 eluted	 by	 enhancing	 the	 ionic	 strength	 alone,	 as	 is	 customary	 for	 AEC	
operations	 (Prazeres	 et	 al.,	 1998;	 Ferreira	 et	 al.,	 2000a;	 Pitarresi	 et	 al.,	 2004).	 The	 mass	
balance	for	pDNA	and	RNA	furthermore	suggests	that	even	after	stripping	the	column	with	
2	M	NaCl	and	0.5	M	NaOH,	some	NA	moieties	are	still	tightly	bound	to	the	core	of	the	media.	










lysate	 containing	 a	 26.88	 kbp	plasmid,	 via	 an	 applied	 salt	 gradient	 leaves	 residual	NA	 still	
bound	to	the	media.	Enhancing	the	salt	concentration	from	1	M	to	2	M	was	insufficient	to	
clear	out	 and	 sanitise	 the	media	 for	 future	applications,	 although	 small	 amounts	of	pDNA	
could	be	eluted	using	2	M	NaCl	(Figure	5-4).	
	













the	 column	 (Figure	 5-5	 ,	 B;	 (Budelier	 et	 al.,	 1998)).	 The	 chaotropic	 agent	 guanidine	
hydrochloride	is	routinely	used	as	an	additive	to	elution	buffer	preparations	for	the	removal	
of	lipids	and	proteins	from	chromatography	resins.	The	moieties	disrupt	the	hydrogen	bonds,	
responsible	 for	 stabilising	bound	molecules	by	weakening	 the	hydrophobic	effect	and	as	a	














Three	 different	 groups	 of	 elution	 buffers	 were	 analysed,	 (i)	 focussing	 on	 different	
concentrations	 of	 NaOH	 and	 isopropanol	 (Biosciences,	 2001;	 Blom	 et	 al.,	 2014),		
(ii)	combinations	of	NaCl	and	Isopropanol,	and	(iii)	stripping	buffer	(2	M	NaCl;	0.5	M	NaOH).	
All	buffer	preparations	from	the	first	group	performed	very	similarly,	eluting	around	80%	of	















Attempts	 to	 determine	 the	 residual	 RNA	 contents	 still	 bound	 to	 CC700	 after	 elution,	 via	
Orcinol	assay	proved	unsuitable,	as	chemical	reactions	with	the	base	matrix	during	sample	






























chromatographic	 media:	 spanQ	 Sepharose	 FF=	 0.995;	 spanSepharose	 6	 FF=	 1.032;	
spanSepharose	CL	6B=	1.054).		
	
	 	 	 	 	 𝑠𝑝𝑎𝑛 =  ,N. ^(,N.)(,N.T) 	 	 	 	 	
	
With	a	volume	weighted	mean	of	D[4,3]	=	86.95	µm,	the	results	confirm	the	manufacturers	














Illustrations	 of	 the	 working	 principle	 of	 the	 ‘core	 bead	 technology’	 depict	 the	 shell	 of	 a	
different	 composition	 than	 the	 core.	 However,	 light	 microscopic	 images	 (Figure	 5-10,	 A)	
suggest	that	the	supports	are	of	homogenous	composition	as	no	change	in	refractive	index	at	
the	interface	between	core	and	shell	can	be	observed.	However,	the	applied	optical	tools	may	



























the	 binding	 behaviour	 and	 spatial	 distribution	 of	 protein	 binding	 in	 CC700,	 BSA	 was	
fluorescently	 tagged	with	CY-5	as	described	 in	2.3.12,	and	 loaded	onto	CC700	 followed	by	
CLSM	analysis.	
The	fluorescence	signals	in	Figure	5-12	confirm	that	BSA	binding	is	limited	to	the	core,	while	
















Analysing	whether	 pDNA	 could	 potentially	 bind	 to	 irregularly	 shaped	 supports,	 CLSM	was	
employed	 to	 trace	 both	 tagged	 BSA	 and	 pDNA	 in	 a	 single	
support	(Figure	5-14).	Against	expectations,	the	entire	support	
was	 surrounded	 by	 a	 thin	 green	 halo	 correlating	 to	 the	
fluorescence	signal	of	tagged	pDNA	molecules.	Although	the	
size	 cut-off	 has	 prevented	 pDNA	 to	 penetrate	 through	 the	
pores	on	the	surface,	pDNA	evidently	was	able	to	bind	to	the	
surface	of	the	media.	
Lowering	 the	 fluorescence	 threshold/	 adjusting	 the	 look	 up	
table	(LUT)	of	images	from	Figure	5-12	does	suggest	miniscule	
binding	 of	 tagged	 BSA	 within	 the	 ‘ligand-free’	 zone	
surrounding	 the	 core	 (Figure	 5-13).	 This	 faint	 glow	may	 result	 from	 unspecific	 binding	 or	
indicate	the	presence	of	very	low	amounts	of	ligands	in	the	shell.	The	strong	negative	charge	

















To	 investigate	 the	 ‘binding’	 of	 pDNA	 to	 the	 surface	 of	 CC700	 supports,	 the	 media	 was	
incubated	with	Syto9	tagged	pDNA	solution	for	various	lengths	of	time.	
5.3.3.	CLSM	analysis	of	pDNA	creeping	into	the	shell	of	Capto	Core	700	over	time	
Feeding	 cleared	 E.	 coli	 lysate	 onto	 a	 CC700	 column	 in	 frontal	 loading	 chromatography	
experiments	have	suggested	that	the	architecture	of	CC700	is	not	truly	inert	to	pDNA	binding.	























Several	 attempts	 have	 been	 made	 to	 explain	 pDNA	 permeation	 through	 nanopores	 in	




To	 confirm	 that	 the	observed	effect	 is	 due	 to	pDNA	binding	 and	not	 a	 result	 of	 artefacts,	












































However,	when	 incubated	with	pDNA	 (especially	 for	 longer	 incubation	periods)	 the	media	
does	bind	low	amounts	of	pDNA	(Figure	5-14).	
Light	microscopy	 image	analysis	 of	 chromatography	media	 indicated	 that	 chromatography	
supports	based	on	Capto	base	matrix	were	in	terms	of	sphericity,	lacking	in	imperfections	and	
monodispersity	 the	 best	 base	 matrix	 for	 cold	 atmospheric	 pressure	 plasma	 treatment	 to	
eliminate	surface	binding	of	AEC	media.	
To	 investigate	 whether	 the	 remaining	 pDNA	 binding	 sites	 of	 CC	 700	 can	 be	 eliminated/	
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plasma	 treatment	 were	 conducted	 for	 30	 min	 and	 120	 min	 incubation	 time	 with	 pDNA	
solution	(1	mL;	15	µg/mL).	
Incubation	 of	 CC700	 with	 pDNA	 solutions	 in	 static	 binding	 studies	 for	 30	 min	 (binding	

































upon	 the	scale	of	operation,	a	plasma	treatment	of	 the	media	prior	 to	 its	use	 in	DSP	may	
reduce	the	overall	costs	associated	to	the	unit	operation,	where	loosing	less	product	due	to	
undesired	 binding	 to	 the	 supports	 is	 only	 one	 of	 the	 advantages;	 CIP	 regimes	 need	 to	 be	








1	mL	 chromatography	 column	packed	with	 the	 SEC-MMC	bilayered	 chromatography	 resin	
yielded	no	breakthrough	of	RNA/	HCP	in	the	flow	through	fractions,	despite	the	overall	low	




























Recent	 advances	 in	 gene	 therapy,	 however,	 have	 opened	 a	 door	 that	 could	 not	 only	
permanently	influence	the	way	we	think,	but	ultimately	who	we	as	humans	are.	We	may	have	
already	entered	the	age	where	human	genetic	augmentation	is	reality	and	even	if	it	still	may	
be	a	young	 field	of	 scientific	 interest,	 the	opportunities	as	well	 as	potential	 consequences	
develop	at	a	very	quick	pace.	









been	 designed	 for	 protein	 based	 products.	 Due	 to	 the	 porous	 structure	 of	 classical	 AEC	
adsorbents,	 pDNA	 binding	 is	 restricted	 to	 the	 supports’	 surface,	 resulting	 in	 poor	 column	
binding	capacities.	
Combining	two	DSP	unit	operations	in	size	exclusion	and	anion	exchange	chromatography	in	






The	 feasibility	 to	 prepare	 multifunctional	 bilayered	 SEC-AEC	 materials	 from	 commercially	
available	 AEC	 media	 in	 a	 ‘top-down’	 approach	 by	 applying	 plasma	 etching	 and	 oxidation	
treatments	to	soft	hydrogel	support	surfaces	was	investigated.	






ESEM	 images	 of	 plasma	 treated	 supports	 yielded	 that,	 unlike	 previously	 reported,	 cold	
atmospheric	pressure	plasma	 treatment	 is	 a	gentle	method,	 that	does	not	alter	 the	visual	
appearance	of	chromatographic	supports	during	treatment.	




adsorbed	 to	 chromatography	 adsorbents,	 revealed	 limitations	 of	 the	 plasma	 etching	 and	
oxidation	technique	due	to	the	presence	of	irregularities	on	the	surface	of	single	adsorbents.	
	
Preparations	 of	 bilayered	 supports	 produced	 via	 ‘bottom-up’	 approach	 of	 AGE	 activation-	
partial	bromination,	controlled	by	viscosity	enhanced	reaction-diffusion	balancing,	led	to	the	
creation	of	‘nice’	supports	in	previous	studies.		
However,	 independent	 of	 associated	 parameters,	 all	 support	 preparations	 resulted	 in	
supports	with	a	minimum	20%	residual	pDNA	binding	capacity,	which	could	not	be	explained.	













The	 commercial	 bilayered	media	 Capto	 Core	 700	was	 successfully	 implemented	 as	 a	 first	
capture	step	for	purifying	a	26.88	kbp	plasmid	from	cleared	E.	coli	lysate,	with	column	binding	
capacity	>80	mL/mLSBV	before	breakthrough.		
Although	 the	 media	 performed	 well	 in	 frontal	 loading	 chromatography	 operations,	 static	
binding	 studies	 revealed	 that	pDNA	 to	bind	 to	 remaining	octylamine	 ligands	on	 the	 ‘inert’	
surface	of	adsorbents,	especially	after	longer	incubation	times.	
These	 observations	were	 confirmed	 by	 CLSM	 analysis	 of	 the	 binding	 topography	 of	 single	
supports,	using	Syto	9	and	Cy5	as	fluorescent	markers	for	pDNA	and	BSA,	respectively.	
By	applying	a	gentle	cold	atmospheric	pressure	plasma	treatment	using	He-O2	as	a	carrier	gas	
in	 a	 FBR	 set-up,	 the	 pDNA	 binding	 to	 Capto	 Core	 700	 was	 reduced	 further	 by	 up	 7.7%,	








While	 exploring	 the	main	 parameters,	 associated	 with	 cold	 atmospheric	 pressure	 plasma	
treatments	 for	 the	 selective	 alteration	 of	 surface	 properties	 of	 beaded	 chromatography	
support	samples	yielded	valuable	insights	as	to	how	the	ROS	interact	with	ligand	structures	
on	the	surfaces	of	soft	hydrogel	chromatography	supports,	 further	parameters	need	to	be	





























In	order	 to	 reduce	 the	 loss	of	 core	binding	capacity	even	 further,	 the	use	of	big	bead	SEC	
















The	 production	 of	 plasmid	 containing	 cells	 was	 conducted	 as	 described	 in	 2.3.2.	 The	


























Figures	 A-4	 to	 A-6	 comprise	 of	 supplementary	 data	 collected	 during	 TOF-SIMS	 analysis	 of	








































Figures	 A-12	 to	 A-14	 depict	 the	 changes	 cold	 atmospheric	 pressure	 plasmas	 have	 on	 CR	
solutions	using	the	same	parameters	and	experimental	set-up	as	for	MO	solutions.	All	trends	
observed	with	the	MO	spectra	repeat	itself	in	the	CR	solutions.	
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Figure	A-7:	Absorbance	spectra	of	azo	dye	solutions	of	CR	(top)	and	MO	(bottom),	initial	(blue	line)	and	
after	10	days	(black	line);	absorbance	corrected	by	background	spectra	of	MQW	in	quartz	cuvette	(red	line)	
	
Figure	A-8:	Peak	absorbance	of	MO	solution	after	contact	with	pure	gas	plasma	treated	MQW	(5	min	
treatment	time);	oxygen	7	W	(solid	line),	10	W	(dashed	line);	7	W	Helium	(dotted	line)	
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Figure	A-9:	Time	resolved	effects	of	cold	atmospheric	pressure	helium	plasma	treatment	of	MO	solution	
(20	µg/mL)	for	different	plasma	treatment	times	(top:	1	min;	middle:	5	min;	bottom:	10	min)	
Spectrum	of	MO	(UV-visible),	pre-plasma	treatment	(blue	line);	immediately	after	the	plasma	treatment	
(solid	line);	after	1	h	(dashed	line);	after	24	h	(dash-dotted	line);	after	5	days	(dotted	line)	
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Figure	A-10:	Time	resolved	effects	of	cold	atmospheric	pressure	He-O2	(99.5%-0.5%	v/v)	plasma	treatment	
of	MO	solution	(20	µg/	mL)	for	different	plasma	treatment	times	(top:	1	min;	middle:	5	min;	bottom:	
10	min)	
Spectrum	of	MO	(UV-visible),	pre-plasma	treatment	(blue	line);	immediately	after	the	plasma	treatment	
(solid	line);	after	1	h	(dashed	line);	after	24	h	(dash-dotted	line);	after	5	days	(dotted	line)	
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Figure	A-11:	Time	resolved	effects	of	cold	atmospheric	pressure	oxygen	plasma	treatment	of	MO	solution	
(20	µg/mL)	for	different	plasma	treatment	times	(top:	1	min;	middle:	5	min;	bottom:	10	min)	
Spectrum	of	MO	(UV-visible),	pre-plasma	treatment	(blue	line);	immediately	after	the	plasma	treatment	
(solid	line);	after	1	h	(dashed	line);	after	24	h	(dash-dotted	line);	after	5	days	(dotted	line)	
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Figure	A-12:	Time	resolved	effects	of	cold	atmospheric	pressure	helium	plasma	treatment	of	CR	solution	
(1.073e-5	mol/L)	for	different	plasma	treatment	times	(top:	1	min;	middle:	5	min;	bottom:	10	min)	
Spectrum	of	CR	(UV-visible),	pre-plasma	treatment	(blue	line);	immediately	after	the	plasma	treatment	
(solid	line);	after	1	h	(dashed	line);	after	24	h	(dash-dotted	line);	after	5	days	(dotted	line)	
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Figure	A-13:	Time	resolved	effects	of	cold	atmospheric	pressure	He-O2	(99.5%-0.5%	v/v)	plasma	treatment	
of	CR	solution	(1.073e-5	mol/L)	for	different	plasma	treatment	times	(top:	1	min;	middle:	5	min;	bottom:	
10	min)	
Spectrum	of	CR	(UV-visible),	pre-plasma	treatment	(blue	line);	immediately	after	the	plasma	treatment	
(solid	line);	after	1	h	(dashed	line);	after	24	h	(dash-dotted	line);	after	5	days	(dotted	line)	
	 -	222	-	
	
	 	
	
	
	
Figure	A-14:	Time	resolved	effects	of	cold	atmospheric	pressure	oxygen	plasma	treatment	of	CR	solution	
(1.073e-5	mol/L)	for	different	plasma	treatment	times	(top:	1	min;	middle:	5	min;	bottom:	10	min)	
Spectrum	of	CR	(UV-visible),	pre-plasma	treatment	(blue	line);	immediately	after	the	plasma	treatment	
(solid	line);	after	1	h	(dashed	line);	after	24	h	(dash-dotted	line);	after	5	days	(dotted	line)	
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A	6.	Protein	binding	isotherm	of	CC700	
	
	
	
Figure	A-15:	BSA	binding	isotherm	of	CC700	
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